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Abstract 
 
 
In November 2004, the OECD Member Countries and the European Commission adopted five 
principles for the validation of (quantitative) structure-activity relationships ([Q]SARs) intended for 
use in the regulatory assessment of chemicals. International agreement on a set of valdation 
principles was important, not only to provide regulatory bodies with a scientific basis for making 
decisions on the acceptability of data generated by (Q)SARs, but also to promote the mutual 
acceptance of (Q)SAR models by improving the transparency and consistency of (Q)SAR reporting 
. 
 
According to the OECD Principles for (Q)SAR validation, a (Q)SAR model that is proposed for  
regulatory use should be associated with five types of information: 1) a defined endpoint; 2) an 
unambiguous algorithm; 3) a defined domain of applicability;  4) appropriate measures of 
goodness-of- fit, robustness and predictivity; and 5) a mechanistic interpretation, if possible. Taken 
together, these five principles form the basis of a conceptual framework for characterising (Q)SAR 
models, and of reporting formats for describing the model characteristics in a transparent manner. 
 
Under the proposed REACH legislation in the EU, there are provisions for the use of estimated data 
generated by (Q)SARs, both as a substitute for experimental data, and as a supplement to 
experimental data in weight-of-evidence approaches. It is foreseen that (Q)SARs will be used for 
the three main regulatory goals of hazard assessment, risk assessment and PBT/vPvB assessment. In 
the Registration process under REACH, the registrant will be able to use (Q)SAR data in the 
registration dossier provided that adequate documentation is provided to argue for the validity of the 
model(s) used.  
 
This report provides preliminary guidance on how to characterise (Q)SARs according to the OECD 
validation principles. It is emphasised that the understanding of how to characterise (Q)SAR models 
is evolving, and that the content of the current report  reflects the understanding and perspectives of 
the authors at the time of writing (November 2005). It is therefore likely that an update will be 
produced in the future for the benefit of those who need to submit (Industry) or evaluate 
(Authorities) chemical information based (partly) on (Q)SARs. It is also noted that this document 
does not provide guidance on the use of (Q)SAR reporting formats, or on criteria for the acceptance 
of (Q)SAR estimates, since EU guidance on these topics stills need to be developed. 
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Abbreviations 
 
AD  Applicability Domain 
AI  Artificial Intelligence 
ANN   Artificial Neural Network 
CEFIC  European Chemical Industry Council 
CI   Confidence Intervals 
CM  Classification Model 
CT  Classification Tree analysis  
DEREK  Deductive Estimation of Risk from Existing Knowledge 
DModX Distance to model in X space 
DModY Distance to model in Y space 
ECETOC  European Centre for Ecotoxicology and Toxicology 
ECM  Embedded Cluster Modelling  
EMS  Explained Mean Square 
FFD Fractional Factorial Design 
GA  Genetic Algorithm 
GHS  Globally Harmonised System (for the classification of chemicals) 
LUMO  Lowest unoccupied molecular orbital  
HOMO Highest occupied molecular orbital 
ICCA   International Council of Chemical Associations 
JRC  Joint Research Centre 
KNN  K-Nearest Neighbour 
LC50  Test concentration causing 50% lethality 
Log Kow Logarithm of the Octanol-Water Partition Coefficient 
Log P   Logarithm of a partition coefficient, e.g. Log (octanol/water) 
LOO Leave-One-Out cross validation technique 
LMO Leave-Many-Out cross validation technique 
LR  Logistic Regression 
LUMO  Lowest Unoccupied Molecular Orbital  
MDA  Multivariate Discriminant Analysis 
MLR Multiple Linear Regression 
MSE Mean Squared Error 
MOA  Mechanism (Mode) of (Toxic) Action 
MR  Molar Refractivity 
MW   Molecular Weight 
NN  Neural Networks 
OECD  Organisation for Economic Cooperation and Development  
PC Principal Component 
PCA   Principal Component Analysis 
PCR  Principal Component Regression 
Pi (p)  Hydrophobicity substituent constant 
PLS Partial Least Squares Projections to Latent Structures 
PRESS PRedictive Error Sum of Squares  
(Q)SAR (Quantitative) Structure-Activity Relationship 
(Q)SBR  (Quantitative) Structure-Biodegradability Relationship 
(Q)SPR (Quantitative) Structure Property Relationship 
RAI  Relative Alkylation Index 
R2 Multiple correlation coefficient 
REACH Registration, Evaluation, and Authorisation of Chemicals 
RMS  Residual Mean Square 
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ROC  Receiver Operating Characteristic 
s Standard error of the estimate 
sigma (s ) Electronic substituent constant 
SDEP Standard Deviation Error of Prediction 
SIDS  Screening Information Data Set 
SMILES  Simplified Molecular Input Line entry system 
SN2  (Bimolecular) Nucleophilic Substitution  
ULR  Univariate Linear Regression 
Vm   Molar Volume 
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CHAPTER 1: INTRODUCTION 
 
Summary of chapter 1 
This chapter provides an introduction to the OECD Guidance Document on (Q)SAR 
Validation, and makes reference to related OECD documents, including the Guidance 
Document 34 on the Validation and Acceptance of Test Methods (para 11), and the Guidance 
Document on the Regulatory Application of (Q)SARs (para 39). The chapter starts with the 
historical background to the establishment of the OECD Principles for (Q)SAR Validation 
and to the development of this document (paras 1-10). The concept of validation, as it applies 
to (Q)SARs, is then defined (paras 11-16), and the intended outcome of a (Q)SAR validation 
exercise is described (paras 17-19). The five validation principles are then presented (para 
20), along with an explanation of the intent of these principles (paras 21-26). The intended 
coverage of the principles is explained (paras 27-28), including the restriction of the 
principles, and this guidance document, to the validation of models rather than software 
packages (para 29-30). The purpose of this guidance document is clarified in (paras 31-33), 
along with the target audience (paras 34-36). Since the validation of (Q)SARs provides a 
basis for their regulatory application, some comments are provided on the boundary between 
validation and regulatory acceptance, which has implications for the limits of this guidance 
document (paras37-40). Finally, this chapter concludes with a brief overview of the rest of 
this document (paras 41-46). 
Historical background 
 
1. A set of six principles for assessing the validity of (Q)SARs were proposed at an 
international workshop on the “Regulatory Acceptance of QSARs for Human Health and 
Environment Endpoints”, organised by the International Council of Chemical Associations 
(ICCA) and the European Chemical Industry Council (CEFIC), and held in Setubal, Portugal, 
on 4-6 March, 2002 (1,2,3,4). 
 
2. The regulatory use of structure-activity relationships (SARs) and quantitative 
structure-activity relationships (QSARs), collectively referred to as (Q)SARs, varies 
considerably among OECD Member Countries, and even between different agencies within 
the same Member Country. This is partly due to different regulatory frameworks, which 
impose different requirements and work under different constraints, but also because an 
internationally harmonised conceptual framework for assessing (Q)SARs has been lacking. 
The lack of such a framework led to the widespread recognition of the need for an 
internationally-agreed set of principles for (Q)SAR validation. The development of a set of 
agreed principles was considered important, not only to provide regulatory bodies with a 
scientific basis for making decisions on the acceptability (or otherwise) of data generated by 
(Q)SARs, but also to promote the mutual acceptance of (Q)SAR models by improving the 
transparency and consistency of (Q)SAR reporting . 
 
3. In November 2002, the 34th Joint Meeting (JM) of the Chemicals Committee and the 
Working Party on Chemicals, Pesticides and Biotechnology agreed to start a new OECD 
activity aimed at increasing the regulatory acceptance of (Q)SARs, and to establish an Expert 
Group for this work. 
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4. The 1st Meeting of the Expert Group was hosted by the European Commission’s Joint 
Research Centre (JRC), in Ispra, Italy, on 31 March - 2 April, 2003. Following the request of 
the 34th JM, the participants of the 1st Expert Group Meeting proposed a (two-year) work 
plan for the OECD work on (Q)SARs. The work plan included three Work Items. The aim of 
Work Item 1, completed in 2004, was to apply the Setubal principles to selected (Q)SARs, in 
order to evaluate the principles, and to refine them wherever necessary. The aim of Work Item 
2 was to develop guidance documents for the validation of (Q)SARs to assist (Q)SAR 
practitoners and (Q)SAR end-users in developing and evaluating (Q)SARs with respect to the 
validation principles.  The aim of Work Item 3 was to identify practical approaches to make 
(Q)SARs readily available and accessible to scientists in regulatory bodies, industry and 
universities. 
 
5. To manage the OECD work plan on QSARs, the 1st Expert Group Meeting proposed 
a subgroup, called the Coordinating Group of the Expert Group on (Q)SARs. In June 2003, 
the proposed work plan was endorsed by the 35th JM. At the same meeting, the European 
Commission (JRC) offered to take the lead in coordinating Work Item 1 on the evaluation of 
the Setubal Principles, with the support of the Coordinating Group. The offer was welcomed 
and accepted by the 35th JM. 
 
6. To carry out Work Item 1, a team of experts (the Work Item 1 Team) produced a 
total of eleven case studies, by applying the Setubal principles to specific (Q)SARs or 
software models. The models chosen included literature-based models for acute fish toxicity, 
atmospheric degradation, mutagenicity and carcinogenicity, and the following software 
models: the Multi-CASE model for in vitro chromosomal aberrations; Multi-CASE and MDL 
models for human NOEL; ECOSAR; BIOWIN; DEREK; the DEREK skin sensitisation 
rulebase; the Japanese METI biodegradation model; and the rat oral chronic toxicity models 
in TOPKAT. These models were considered to collectively provide a representative range of 
(Q)SAR approaches, covering a variety of physicochemical, environmental, ecological and 
human health endpoints.  
 
7. To provide guidance on the application of the proposed principles, a check list of 
considerations (questions) was developed by the Coordinating Group, and this was refined on 
the basis of experience obtained by carrying out Work Item 1). The refined check list was 
presented to the 16th Meeting of the Working Group of National Coordinators of the Test 
Guidelines Programme, held on 26-28 May 2004. 
 
8. The report on the outcome of Work Item 1 was discussed by the 2nd Expert Group 
Meeting, hosted by the OECD, in Paris, on 20-21 September 2004. The report consisted of a 
consolidated report by the Coordinating Group, including a proposal for revision of the 
Setubal principles, followed by a set of annexes containing the 11 case studies. The Expert 
Group refined the wording of the consolidated report, which included combining the internal 
and external validation principles into a single principle (5), which then represented the 
consensus view of the Expert Group. It was also agreed that the views expressed in the 
annexes (6) should be regarded as views of the identified authors, and not necessarily the 
views of the Expert Group. 
 
9. The final report on the outcome of Work Item 1 (5,6), and in particular the proposed 
OECD Principles for (Q)SAR Validation, were adopted by the 37th JM on 17-19 November 
2004. The JM supported the Expert Group’s proposal that Work Item 1 should be followed up 
with Work Item 2 in the development of this Guidance Document on (Q)SAR Validation, 
  6 
which should provide detailed and non-prescriptive guidance to explain and illustrate the 
application of the OECD Principles for (Q)SAR Validation to different types of models.  
 
10. The 37th JM also agreed on some changes in the coordination of the OECD QSAR 
work programme. In particular, oversight of the (Q)SAR project was assigned to the Task 
Force on Existing Chemicals, and the name of the (Q)SAR Group, often referred to as the 
“(Q)SAR Expert Group”  was changed to “Ad hoc Group on (Q)SARs”. At the same time, the 
membership of the Ad hoc Group was re-established. Following receipt of the nominations 
from the Member Countries, the 38th JM on 8-10 June 2005 agreed to replace the 
Coordinating Group with a smaller Steering Group, consisting of those members of the Ad 
Hoc Group who are most closely involved in the planning and routine management of the 
(Q)SAR project. 
Definition of “validation” and the “validation process” in the context of (Q)SARs 
Definition of (Q)SAR validation 
11. The guidance for (Q)SARs in the present document is consistent with the general 
guidance given in OECD Guidance Document 34 on the Validation and International 
Acceptance of New or Updated Test Methods for Hazard Assessment (7). 
 
12. According to OECD Guidance Document 34, the term “validation” is defined as 
follows: 
 
“Validation is the process by which the relevance and reliability of a method are assessed for 
a particular purpose”. 
 
In this definition, relevance refers to the scientific (mechanistic) basis of the experimental 
method and to the predictive ability of an associated prediction model (in the case of methods 
where an extrapolation is made across an endpoint and/or species), whereas reliability refers 
to the reproducibility of the method, both within and between laboratories, and over time. 
  
13. An adaptation of this definition is needed for (Q)SARs to account for the fact that a 
(Q)SAR is a derivative of experimental data and not the experimental method itself. The term 
“relevance” is applicable to (Q)SARs, if this is interpreted as referring to the predictive ability 
of the model and to the possibility to interpret the model in mechanistic terms. Since a 
(Q)SAR is a derivative of the experimental data, the mechanistic relevance of the model is 
logically tied to the corresponding endpoint of the experimental method, irrespective of 
whether this test method is itself considered to be relevant for any particular purpose. The 
assessment of (Q)SAR reliability, however, places greater emphasis on the accuracy of the 
(Q)SAR with many different chemicals than on the reproducibility of the (Q)SAR within and 
between laboratories. In other words, the assessment of reliability within a specific chemical 
universe (applicability domain) is emphasised more than the reproducibility of individual 
endpoint estimations. In contrast, the validation of experimental methods has traditionally 
placed less emphasis on the importance of the chemical domain when assessing the validity of 
the results. 
 
14. An adaptation of this definition is needed for (Q)SARs, for the following reasons: a) 
(Q)SAR models are not test methods, which implies some differences between the validation 
approaches adopted for (Q)SARs and those adopted for test methods; b) in the (Q)SAR field, 
the term “reliability” is generally used to reflect “accuracy” or “validity”, rather than 
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reproducibility; and c) the reproducibility of a (Q)SAR does not normally need to be assessed 
during validation, because the predictions generated by such a model are not expected to 
exhibit significant intra- laboratory and inter-laboratory variability, such as that associated 
with experimental  methods.  
 
15. In relation to (Q)SARs, the following adaptation of the traditional definition of 
validation is proposed: 
 
“The validation of a (Q)SAR is the process by which the performance and mechanistic 
interpretation of the model are assessed for a particular purpose.” 
 
In this definition, the “performance” of a model refers to its goodness-of-fit, robustness and 
predictive ability, whereas “purpose” refers to the scientific purpose of the (Q)SAR, as 
expressed by the defined endpoint and applicability domain. The first part of the definition 
(performance) refers to “statistical validation”, whereas the second part (mechanistic 
interpretation) refers to the assignment of physicochemical meaning to the descriptors (where 
possible) and to the establishment of a hypothesis linking the descriptors with the endpoint.  
 
16. The scientific purpose of a (Q)SAR may or may not have an association with 
possible regulatory applications. Thus, the purpose of a (Q)SAR could be for predicting a 
particular endpoint (along a continuous or categorical scale) for a particular class of 
chemicals, irrespective of whether the endpoint is required by any particular legislation or 
whether the class of chemicals is contained with a given regulatory inventory. 
 
 
The (Q)SAR validation process 
17. For the purposes of this guidance document, a “validation process” refers to any 
exercise in which the OECD principles for (Q)SAR validation are applied to a given model or 
set of models. It is not implied that the validation process should be carried out by any 
particular organisation, committee or formal validation body.  
 
18. The outcome of a (Q)SAR validation process should be a dossier providing 
information on the validity of a (Q)SAR. The information should be obtained by applying the 
(Q)SAR validation principles, and the dossier should be structured accordingly. For scientific 
and/or practical reasons, it will not be possible to fulfill all principles for all models of 
regulatory interest. Therefore, the output of a successful validation exercise is the provision of 
a dossier that is as complete as possible, given the scientific and practical constraints. The 
output of a successful validation process does not need to include any opinion on the validity 
of a model.  
 
19. It follows that each regulatory authority will need to apply flexibility when 
considering the acceptability of a given (Q)SAR, taking into account the information provided 
in the (Q)SAR validation dossier, and the needs and constraints of the its particular regulatory 
programme. 
The OECD Principles for (Q)SAR Validation 
20. On the basis of the Work Item 1 report (5,6), the 37th Joint Meeting agreed on the 
following wording of the OECD Principles for (Q)SAR validation: 
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“To facilitate the cons ideration of a (Q)SAR model for regulatory purposes, it should be 
associated with the following information: 
 
1) a defined endpoint; 
2) an unambiguous algorithm; 
3) a defined domain of applicability; 
4) appropriate measures of goodness-of- fit, robustness and predictivity; 
5) a mechanistic interpretation, if possible.” 
 
These principles should be read in conjunction with the explanatory notes presented in the 
following section.   
 
Intent of the (Q)SAR validation principles  
21. The principles for (Q)SAR validation and the associated check list are intended to 
identify the types of information that are considered useful for the regulatory review of 
(Q)SARs. Taken together, the principles and check list constitute a conceptual framework to 
guide the validation of (Q)SARs, but they are not intended to provide criteria for the 
regulatory acceptance of (Q)SARs. The definition of acceptance criteria, where considered 
necessary, are the responsibility of individual authorities within the Member Countries. 
 
22. According to Principle 1, a (Q)SAR should be associated with a “defined endpoint”, 
where endpoint refers to any physicochemical, biological or environmental effect that can be 
measured and therefore modelled. The intent of this principle is to ensure transparency in the 
endpoint being predicted by a given model, since a given endpoint could be determined by 
different experimental protocols and under different experimental conditions. Ideally, 
(Q)SARs should be developed from homogeneous datasets in which the experimental data 
have been generated by a single protocol. However, this is rarely feasible in practice, and data 
produced by different protocols are often combined.  
 
23. According to Principle 2, a (Q)SAR should be expressed in the form of an 
unambiguous algorithm. The intent of this principle is to ensure transparency in the 
description of the model algorithm. In the case of commercially developed models, this 
information is not always made publicly available. 
 
24. According to Principle 3, a (Q)SAR should be associated with a “defined domain of 
applicability”. The need to define an applicability domain expresses the fact that (Q)SARs are 
reductionist models which are inevitably associated with limitations in terms of the types of 
chemical structures, physicochemical properties and mechanisms of action for which the 
models can generate reliable predictions. This principle does not imply that a given model 
should only be associated with a single applicability domain. As discussed in Chapter 3, the 
boundaries of the domain can vary according to the method used to define it and the desired 
trade-off between the breadth of model applicability and the overall reliability of predictions. 
 
25.  According to Principle 4, a (Q)SAR should be associated with “appropriate 
measures of goodness-of–fit, robustness and predictivity.” This principle expresses the need 
to provide two types of information: a) the internal performance of a model (as represented by 
goodness-of- fit and robustness), determined by using a training set; and b) the predictivity of 
a model, determined by using an appropriate test set. As discussed in Chapter 4, there is no 
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absolute measure of predictivity that is suitable for all purposes, since predictivity can vary 
according to the statistical methods and parameters used in the assessment. 
 
26. According to Principle 5, a (Q)SAR should be associated with a “mechanistic 
interpretation”, wherever such an interpretation can be made. Clearly, it is not always possible 
to provide a mechanistic interpretation of a given (Q)SAR. The intent of this principle is 
therefore to ensure that there is an assessment of the mechanistic associations between the 
descriptors used in a model and the endpoint being predicted, and that any association is 
documented. Where a mechanistic interpretation is possible, it can also form part of the 
defined applicability domain (Principle 3). 
 
Coverage of the (Q)SAR validation principles 
27. The (Q)SAR validation principles are intended to be applicable to a diverse range of 
models types including SARs, QSARs, decision trees, neural network models, and “complex 
models”, such as expert systems, which may be based on the use of multiple models. The 
guidance provided in this document is intended to reflect this diversity of model types. 
 
28. In the case of “complex models” that are actually based on the use of multiple 
models, it is important to identify the smallest component that functions independently, and to 
apply the principles to the individual component. Examples of such models include ECOSAR 
and DEREK for Windows. 
 
Model validation vs software verification 
29. This guidance document covers the validation of models, but not the verification of 
computer programmes. It is important to distinguish between models, which are 
generalisations (based on theory or observation) used to make predictions, and computer 
programmes, which may be developed to implement models on particular computer 
platforms. Furthermore, it is important to distinguish between the validation of a model, and 
the verification of the software programme that applies the model. A highly predictive model 
could be regarded as valid, without considering whether the model has been coded correctly 
in the form of a computer programme. Conversely, a poorly predictive model, which might 
not be regarded as valid, could be accurately translated into a specific programming language 
for implementation in a specific software package.  
 
30. In principle, any model could be implemented in a variety of computer platforms, 
However, in practice, for certain types of models, it may be difficult to separate the model 
from the platform. This is particularly true of commercially available models, where certain 
components of the model (e.g. training sets, algorithms) are hidden for proprietary purposes. 
 
Purpose of this guidance document 
31. The purpose of this document is to provide detailed and non-prescriptive guidance 
that explains and illustrates the application of the validation principles to different types of 
(Q)SAR models.  
 
32. This document is needed to: a) present a harmonised conceptual framework to guide 
the conduct of (Q)SAR validation studies and to help regulators who will need to consider the 
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outcome of such studies; and b) explain and illustrate with examples how the validation 
principles can be interpreted for different types of models. 
 
33. The establishment of criteria for determining the scientific validity and regulatory 
acceptability of (Q)SARs is not covered by this document. Where considered necessary, it is 
expected that such criteria will be established by the appropriate regulatory authorities. 
 
Target audience 
34. This document is aimed primarily at (Q)SAR specialists who need to carry out 
(Q)SAR validation exercises. Therefore, the guidance will be based on the assumption that 
the reader is familiar with the basics of (Q)SAR.  
 
35. At a secondary level, the document will be aimed at non-specialist stakeholders of 
the validation process who will not need to perform validation exercises themselves, but who 
will need a sufficient conceptual basis for understanding their outcome. For example, 
regulators may need to assess the outcome of a (Q)SAR validation exercise, without 
necessarily conducting the exercise themselves. 
 
36. To accommodate both types of readership, each chapter contains a summary, written 
at a more general level for the non-specialist. Each chapter summary makes reference to 
specific sections of the chapter where the specialist reader can find more detailed information. 
 
Regulatory application of (Q)SARs 
37. As mentioned above, the aim of this document is to provide guidance on how the 
(Q)SAR validation principles can be applied to different types of models, not to define criteria 
for the validity or acceptability of (Q)SARs. 
 
38.  In cases where the application of the principle is inherently subjective, guidance is 
provided through the use of examples taken from the (Q)SAR literature. In cases where 
statistical methods or other approaches are available for applying a principle, the current state-
of-the-art is described, and advice is given on the strengths and limitations of different 
approaches. 
 
39. Flexibility will be needed in the interpretation and application of each principle 
because ultimately, the proper integration of (Q)SARs into any type of regulatory/decision-
making framework depends upon the needs and constraints of the specific regulatory 
authority. The need for such flexibility is given in a case study by the US EPA (8).  
 
40. A separate document on the regulatory application of (Q)SARs is being developed 
by the OECD Ad hoc Group on (Q)SARs (9), under the coordination of the US EPA.  
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Overview of this document 
41. Each chapter of this document addresses the application of one or more principles. 
 
42. Chapter 2 provides examples to illustrate how the concepts of “unambiguous 
algorithm” and “defined endpoint” can be interpreted in relation to different types of 
(Q)SARs. 
 
43. Chapter 3 describes the current state-of-the-art of statistical methods and other 
approaches for the assessment of the applicability domains of (Q)SARs. 
 
44. Chapter 4 describes the current state-of-the-art of statistical methods and other 
approaches for assessing the goodness-of-fit, robustness and predictivity of (Q)SARs, and 
explains the concepts of internal and external validation. This chapter also illustrates, by 
means of flow charts, logical sequences of steps that could be taken during the validation of 
(Q)SARs. 
 
45. Chapter 5 provides examples to illustrate how the concept of “mechanistic 
interpretation” can be applied to (Q)SARs, where feasible. The mechanistic interpretation of a 
(Q)SAR includes  two considerations: a) the interpretation of the (Q)SAR descriptors and 
consequently their relevance for the prediction of the endpoint; b) the relevance of the 
mathematical form of the relationship between the descriptors and the endpoint being 
modelled. 
 
46. Appendix 1 provides a check list of questions to help in the application of the OECD 
principles for QSAR validation. 
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CHAPTER 2: DEFINED ENDPOINT AND ALGORITHM 
 
Summary of chapter 2  
 
This chapter introduces the rationale behind the first two OECD validation principles, 
according to which a (Q)SAR should be associated with a “defined endpoint” (Principle 1) 
and with a “unambiguous algorithm” (Principle 2).  Guidance is provided on the interpretation 
of these principles, by describing what constitutes a defined endpoint and an unambiguous 
algorithm. Following an introduction to the establishment of the principles (paras 1-2), the 
concept of the defined endpoint is discussed (paras 3-7), followed by the concept of the 
defined algorithm (paras 8-12) is emphasised that a defined endpoint in the context of test 
guidelines does not necessarily correspond with a defined endpoint in the context of (Q)SAR 
development. The need for a defined algorithm is discussed in terms of the elements that are 
needed for an algorithm to be fully transparent. 
 
Introduction 
 
1. According to Principle 1, a (Q)SAR should be associated with a “defined endpoint”, 
where endpoint refers to any physicochemical, biological or environmental effect that can be 
measured and therefore modelled. The intent of this principle is to ensure transparency in the  
endpoint being predicted by a given model, since a given endpoint could be determined by 
different experimental protocols and under different experimental conditions. When making a 
comparison between (Q)SAR predictions with experimental data, it is important to know 
whether the model was intended to generate the same type of information.  It is also important 
to know whether the experimental data used to develop the model were generated according 
to a single experimental protocol, or whether data from different protocols were merged in the 
training set. Ideally, all (Q)SARs should be developed by using data generated by a single 
protocol, but this is rarely  feasible in practice. In the case of commercially developed models, 
information on the training sets is not always made publicly available. 
 
2. According to Principle 2, a (Q)SAR should be expressed in the form of an 
“unambiguous algorithm”. The intent of this principle is to ensure transparency in the 
description of the model algorithm. In the case of commercially developed models, a 
unambiguous definition of the algorithm(s) used is not always made publicly available. 
 
A defined endpoint  
 
3. A (Q)SAR is a qualitative or quantitative relationship between chemical structure and 
the property or (biological) activity being modelled. The property or (biological) activity is 
called the “endpoint”, whereas the form of the relationship is called the “algorithm”. 
 
4.   The endpoint is often determined in accordance with an experimental protocol, and in 
the case of an endpoint of regulatory interest, with a test guideline (e.g. an EU Test Method or 
an OECD Test Guideline). Commonly used test guideline endpoints that are used in the 
assessment of chemicals are listed in Table 2.1. In the context of a test method, a well-defined 
endpoint is a property or effect that is measured according to a well-defined (standardized) set 
of experimental conditions. 
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5. (Q)SARs are often developed for well-defined (test method) endpoints. However, if 
the development of (Q)SARs is compared with that of test methods, several difference of 
emphasis can be noticed. For example, it is often assumed that the applicability domain (AD) 
of a test method is “global” in terms of its coverage of physicochemical space, whereas the 
AD of a (Q)SAR is generally assumed to be limited in one more respects. This means that, in 
general, a single (Q)SAR can only be expected to give comparable data to a test method when 
it is applied within its AD, and multiple (Q)SARs are often needed to make reliable 
predictions for a diverse range of chemicals. For this reason, research is being carried out into 
the development of methods and tools for combining the use of (Q)SARs. 
 
6. Another difference between (Q)SARs and test methods is that the defined endpoints of 
many (Q)SARs are actually different to test method endpoints. In such cases, it should be 
considered whether the (Q)SAR gives “equivalent” data, which may be useful for hazard and 
risk assessment purposes, but it should not be assumed that the (Q)SAR gives “comparable”  
data, in the sense that the (Q)SAR data is directly predictive of the experimental data.  
 
7. Even if a (Q)SAR is developed for a well-defined test method endpoint, the nature of 
the test method will affect the feasibility of producing a meaningful and predic tive model. For 
example, it has been possible to develop reliable QSAR models for acute toxicity in fish, 
because the experimental protocol results in a steady-state concentration of the chemical 
between the blood and exposure medium. In such cases, it has been possible to relate 
quantitative variations in the endpoint (acute lethal toxicity) to (quantitative) variations in 
physicochemical structure. In contrast, it has been more difficult to develop meaningful and 
predictive models of acute oral toxicity in mammalian organisms, because it is difficult to 
separate the effect of chemical structure on potency from the effect of the organism on the 
kinetics of the chemical. Variations in the internal exposure conditions make it difficult to 
identify to inherent potency of the chemical. 
 
Unambiguous algorithm 
 
8. The need for a (Q)SAR to be associated with an unambiguous algorithm reflects the 
need of the end-user to understand how the estimated value was generated, and to be able to 
reproduce the algorithm and/or the estimates. When the underlying algorithm of a (Q)SAR 
model is not transparent to the user, the model is sometimes referred to as a “black box”.  
 
9. Principle 2 refers to the algorithm used to make a prediction of an endpoint on the 
basis of one or more descriptors. In many cases, it is possible to be transparent about this 
algorithm without necessarily being transparent about the (mathematical) method used to 
develop the algorithm. For example, a regression-based QSAR can be defined explicitly 
without any description of the regression approach. In addition, an expert rule can be stated 
explicitly, without any indication of how the rule was developed. In some cases, expert rules 
have been generated by automated procedures, so in principle the same procedures could be 
used to re-derive the rules. However, in other cases, expert rules simply codify the knowledge 
of experts, so no automated procedure can be used to re-derive the rule.  
 
10. For certain types of model, the definition of the algorithm is more closely associated 
with the way in which it was derived (e.g. a neural network model which includes both a 
learning process and a prediction process).  
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11. An important component of an unambiguous algorithm is the availability of 
information on the descriptors used to link chemical structure with the predicted endpoint. 
Broadly, descriptors can be distinguished into thre main types:  
 
a) descriptors based on chemical graph theory 
b) descriptors based on experimental measurements 
c) descriptors based on theoretical quantum mechanical calculations 
 
Descriptors based on chemical graph theory are sometimes called toplogical descriptors. 
Examples include the molecular connectivity indices (10,11,12,13). Descriptors based on 
experimental measurements (e.g. logP) have traditionally been used most widely, as reviewed 
by Verhaar et al. (14). Increasingly, methods for predicting such descritpors are being used as 
a substitute for the experimental data. The third category of descriptors refers to a range of 
descriptors for predicting the electronic properties of molecules. These descritpors are either 
generated by semi-empirical models or more precise (and cmoutational intensive) ab initio 
methods. Some of the properties calculated by these methods can be measured (e.g. the 
HOMO energy) whereas others cannot be directly measured (e.g. LUMO energy). Some of 
these descriptors are useful for predicting chemical reactivity, and therefore for modelling 
chemical toxicity that results from reactions with cellular chemicals and macromolecules 
(14,15,16). 
 
12. It is important to distinguish between the transparency of the algorithm and its 
mechanistic interpretability. For example, a statistically-based QSAR can be transparent in 
terms of its predictor variables and coefficients, but the descriptor variables themselves may 
not have an obvious physicochemical meaning or plausible causal link with the endpoint 
being modelled. The mechanistic interpretation of (Q)SARs is addressed in Chapter 5. 
 
Conclusions  
13. For (Q)SAR purposes, a well-defined endpoint should ideally be based on 
experimental data generated by a standardised test protocol. In the case of (Q)SARs 
developed by using data from different protocols, the differences in the experimental 
conditions should not lead to significantly different values of the endpoint.  
 
14. In the case of QSARs, i.e. quantitative relationships based on numerical measures of 
chemical structure, a well-defined endpoint is an endpoint that can be quantified in a way that 
reflects differences between chemical structures.  
 
15. Transparency in the (Q)SAR algorithm can be provided by means of the following  
information: 
 
a) An explicit definition of the mathematical form of a QSAR model, or of the decision 
rule (e.g. in the case of a SAR) 
b) Definitions of all descriptors in the algorithm, and a description of their derivation  
c) Details of the training set used to develop the algorithm. 
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Table 2.1 Endpoints associated with EU Test Methods and OECD test guidelines 
 
Physicochemical Properties    
Melting Point       
Boiling Point      
Vapour Pressure     
K  octanol/water partition coefficient     
Koc organic carbon/water partition coefficient 
Water Solubility 
 
Environmental Fate 
Biodegradation  
Hydrolysis in water  
Atmospheric Oxidation 
Bioaccumulation 
 
Ecological Effects     
Acute Fish      
Long-term Toxicity     
Acute Daphnid      
Alga       
Terrestrial toxicity 
 
Human Health Effects 
Acute Oral 
Acute Inhalation  
Acute Dermal        
Skin Irritation 
Eye Irritation 
Skin Sensitisation 
Repeated Dose Toxicity 
Genotoxicity (in vitro, bacterial cells) 
Genotoxicity (in vitro, mammalian cells) 
Genotoxicity (in vivo) 
Reproductive Toxicity 
Developmental Toxicity 
Carcinogenicity 
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CHAPTER 3: (Q)SAR APPLICABILITY DOMAIN  
 
 
Summary of Chapter 3  
 
Chapter 3 provides guidance on how to interpret OECD validation principle 3 that “a (Q)SAR 
should be associated with a defined domain of applicability”. This principle expresses the 
need to establish the scope and limitations of a model based on the structural, 
physicochemical and response information in the model training set. The importance of the 
principle lies in the fact that a given model can only be expected to give reliable predictions 
for chemicals that are similar to those used to develop the model. Predictions that fall outside 
the applicability domain (AD) represent extrapolations, and are less likely to be reliable. 
When applying a (Q)SAR, it is important to know whether its AD is known, and whether it is 
being used inside or outside of this boundary. In its simplest form, the assessment of whether 
a chemical is located in the AD can be expressed categorically (i.e. yes or no). For a 
quantitative assessment, it is possible to associate a confidence interval with the AD, to 
determine the degree of similarity between the chemical of interest and the model training set. 
This chapter begins by explaining of the need for defining the AD (paras 1-4), before 
introducing some basic concepts and definitions (paras 5-11). The chapter then provides a 
review of different methods that are currently available or under development for identifying 
and quantifying the applicability domain, with some examples to illustrate their applicability 
(paras 12-34). It is emphasised that the subject of the (Q)SAR AD is an evolving field of 
research, and some research needs are presented in the concluding remarks of the chapter 
(para 36-40). 
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Introduction  
 
1. The principle that “a (Q)SAR should be associated with a defined domain of 
applicability” expresses the need to provide supporting information on the applicability of a 
(Q)SAR to unknown chemicals. This need is based on the fact that (Q)SARs are reductionist 
models which are inevitably associated with limitations in terms of the types of chemical 
structures, physicochemical properties and mechanisms of action for which the models can 
generate reliable predictions. In principle, every (Q)SAR model can be associated with an 
applicability domain (AD), even though this has not always been done explicitly in the QSAR 
literature. 
 
2. Information on the AD helps the user of the model to judge whether the prediction for 
a new chemical is reliable or not. The definition of the AD is based on the assumption that a 
model is capable of making reliable predictions only within the structural, physicochemical 
and response space that is known from its training set. Thus, the model fit, robustness and 
predictivity determined by statistical methods (see Chapter 4) are meaningful only if they are 
used for chemicals in the AD. Even within the AD of a model, different degrees of confidence 
can be associated with different predictions. 
 
3. The assessment of whether a chemical falls within the AD of a model is based on an 
assessment of the similarity between the chemical and the training set. Since there are many 
different ways of expressing similarity (often defined in physicochemical properties), it 
follows that many different methods for defining the AD can be developed. Indeed, a variety 
of methods have been proposed, each of which is associated with strengths and limitations 
(17).  
 
4. The third OECD validation principle does not imply that each (Q)SAR is associated 
with a single AD. There is no absolute boundary between reliable and unreliable predictions. 
This can be fixed by the model user, according to the performance characteristics of the 
model and the context in which the model is being applied. In general, there is a trade-off 
between the breadth of the AD and the overall reliability of prediction: the broader the AD, 
the fewer chemicals that can be predicted with a given reliability.  
 
  
Basic Terms and Concepts 
 
5. Several definitions of the AD can be found in the (Q)SAR literature, but probably the 
most broadly applicable definition is the following (17): 
 
“The applicability domain of a (Q)SAR model is the response and chemical structure space in 
which the model makes predictions with a given reliability. ” 
 
6. In this definition, chemical structure can be expressed by information on 
physicochemical properties and/or structural fragments, and the response can be any 
physicochemical, biological or environmental effect that is being predicted (i.e. the defined 
endpoint, see Chapter 2). The relationship between chemical structure and the response can be 
expressed by a variety of SARs and QSARs.  
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7. The AD concept should be applied in a model-specific manner. Thus, every model 
should be associated with its own AD. It depends not only on the chemicals in the training set 
but also on the descriptors and (statistical) approach used to develop the model. Thus, the 
same training set could in principle be used to develop multiple QSARs, differing in terms of 
their descriptors and/or mathematical form, and with different ADs.  
 
8. Ideally, the AD should be defined and documented by the model developer. However, 
this information is often lacking in the reports of (Q)SAR studies. In principle, it should be 
possible for an independent (Q)SAR practitioner to define (or confirm) the AD of an existing 
model, provided that a sufficient amount of background information is available. This 
information should include: a statement of the unambiguous model algorithm (see Chapter 2), 
details of the training set (chemical identification, descriptors and endpoint values), and 
details of the (statistical) method to derive the model.   
 
9. Ideally, the AD should express the structural, physicochemical and response space of 
the model. This is because the best assurance that a chemical is predicted reliably is to have 
confirmation that the chemical is not an outlier in terms of its structural fragments (structural 
domain), its descriptor values (physicochemical domain) or its response values (response 
domain). In some cases, a model can predict reliably beyond its physicochemical domain, 
especially if it is still within its structural domain. 
 
10. Even though a well-defined AD helps the user of the model to assess the reliability of 
predictions made by the model, it should not automatically be assumed that all predictions 
within the defined AD are necessarily reliable. In practice, a prediction could still be 
unreliable even though the chemical lies within the established structural and 
physicochemical domains of the model. This could occur in cases where the chemical of 
interest acts by a different mechanism of action, not captured by the model. If more than one 
such chemical is discovered, the QSAR practitioner could either try to refine the model, to 
accurately predict the outliers, or could try to define an exclusion rule. The need to account 
for such outliers has also led to the concept of the mechanistic domain. Thus, for some 
models, the application of OECD validation principle 3 is linked with the application of 
principle 5 on mechanistic interpretation. 
 
11. The concept of AD should be applied only to statistically validated (Q)SARs, i.e. 
(Q)SARs that are based on statistically significant relationships, and not on random models, 
where fundamental statistical principles are violated (see Chapter 4).  
 
Recommendations for Practitioners  
 
12. Historically, the first QSAR models were developed for homologous series of 
chemicals. Although these models may have limited use today, they are helpful to illustrate 
how the concept for the AD can be applied. For example, if one knows the narcotic effects of 
the primary alcohols ethanol, propanol, butanol, hexanol and heptanol, then one can predict 
the narcotic effect of pentanol by the linear relationship between the narcotic effect and 
molecular weight (MW). Pentanol is in the AD of this simple model because it is a structural 
homologue of the other alcohols and has a MW intermediate to two other alcohols. The 
alcohols methanol and the octanol, however, would not be considered in the AD of the model 
because, because while they are structural homologues of the other alcohols, they have MW 
values lower than ethanol and greater than heptanol, respectively (Figure 3.1).  
  21 
 
 
 
Narcotic effect 
Molecular weight 
 
 
 
 
    
methanol ethanol propanol butanol pentanol hexanol heptanol octanol 
 
 
Figure 3.1 
 
13. Other examples support the same reasoning. For example, Hermens et al. (18) have 
shown that increasing the number of carbon atoms in a homologue series of aldehydes above 
10 leads to a change of the mechanism of action. The consequence is that the relationship 
between the toxicity and the octanol-water partition coefficient (log Kow), found for lower 
members of the series, does not hold true for the higher members. In another example, Schultz 
et al. (19) showed that acrolein, the first chemical in the series of a,b-unsaturated aldehydes, 
was considerably more toxic than predicted by the relationship between log Kow and toxicity 
for the other a,b-unsaturated aldehydes. 
 
14. In addition to the physicochemical and structural domains, an additional useful 
element in the AD definition is an understanding of the mechanism of action (MOA) of the 
chemicals used to develop a model (i.e. the mechanistic domain). For example, the phenols 
and the anilines (if not complicated by more reactive moieties) demonstrate polar narcosis in 
aquatic organisms (20) even though they belong to different chemical classes. Thus, the 
effects of chemicals belonging to both chemical classes can be predicted by a single model 
provided the chemical does not go beyond the range of physicochemical parameters used to 
develop the model. The grouping of chemical classes into single QSARs is endpoint-specific 
because the different classes might not behave in the same way for a different endpoint (e.g. 
mutagenicity). In fact, aromatic amines have considerable potential to cause mutations 
whereas phenols do not. 
 
15. Chemicals that contain multiple functional groups deserve special attention. Such 
chemicals might exhibit enhanced effects as a result of synergism or even exhibit a different 
MOA. Such chemicals are likely to be outliers to well established relationships. An example 
is provided by the a-halogenated esters (21), in which the presence of a halogen atom on an 
aliphatic hydrocarbon chain does not alter the narcosis MOA for aquatic toxicity. Aliphatic 
esters also act as narcotics in aquatic organisms. However, the presence of a halogen atom at 
the a-position to the carbonyl group of an aliphatic ester results in a drastic increase of 
toxicity due to the fact that this arrangement of atoms undergoes an SN2 reaction (the halogen 
atom being the leaving group) with macromolecules. 
 
16. The identification of special atom arrangements (toxicophores) that cause certain types 
of toxicity provides a way of defining mechanistic domains. Expert judgement is required 
since the expected toxicological profile could be modulated by the presence of additional 
functional groups (modulators), which may increase or decrease the toxicity.  For example, 
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the methyl groups usually increase the toxicity due to increased lipophilicity without changing 
the MOA. Thus, the methylphenols are slightly more toxic to fish than the parent phenol (22). 
However, methyl groups can also block completely the toxicophore; for example the methyl 
groups in the tert-butyl group decrease the toxicity of tert-butyl acrylate (23). The presence of 
a bulky substituent next to a reactive group is one reason why a chemical might fall outside 
the expected mechanistic domain. The properties of such chemicals or are usually 
overestimated. 
 
17. Inaccuracy of prediction can appear also if a chemical undergoes metabolic 
transformation. Such chemicals appear outliers from many different (Q)SAR models 
irrespectively of whether the model was developed on a mechanistic basis or statistically. The 
reason for miss-prediction in this case is that the chemical that causes the effect is different 
from the chemical that was introduced to the biologic system and these out-of-the-domain 
chemicals are usually most difficult to identify a priori. An example could be given with 1,2- 
and 1,4-dihydroxybenzenes that exhibit enhanced toxicity because of transformation to 1,2- 
and 1,4-quinones with strong electrophilic potential, or formation of free-radical species (24). 
 
18. At present, the identification of mechanistic domains relies heavily on expert 
judgement. There are, however, some software tools that can assist in the identification of 
potential toxicophores and modulators. An example is the DEREK software (Lhasa Ltd), an 
expert system that applies knowledge-based rules for toxicity prediction. A similar 
functionality is available in HazardExpert (Compudrug.Inc.), which issues an alert if a toxic 
fragment is found in the query molecule. Another program for toxicity prediction, 
MULTICASE (Multicase Inc.), evaluates the structural features of molecules from non-
congeneric series and identifies substructural fragments that are considered responsible for a 
certain type of activity. The TOPKAT software (Accelrys Inc.) uses an initial classification 
into chemical classes before applying quantitative models for toxicity prediction. Various 
software products incorporate knowledge about metabolism and can therefore be used to 
anticipate the metabolites of the chemical of interest. These systems include CATABOL 
(Laboratory of Mathematical Chemistry, Bulgaria) and MetabolExpert (CompuDrug Inc.). 
 
19. As expressed by OECD principle 5, it is useful if the (Q)SAR can be interpreted in 
mechanistic terms (see Chapter 5). However, this is not always possible, in part because the 
underlying mechanisms of many toxic effects are simply not known.  It is also not essential, 
since robust models can be develop by purely statistical means. For the purposes of this 
chapter, it should be noted that the different assumptions behind mechanistic and statistical 
(Q)SARs imply the need for different types of tool for defining the AD. 
 
20. If a (Q)SAR is based on physicochemical descriptors, the interpolation space (i.e. its 
coverage), defined by its descriptors, should be characterised. The interpolation space of a 
one-descriptor model is simply the range between the minimum and the maximum value of 
that descriptor, as observed in the training set of the model. The interpolation space of multi-
descriptor models is more complex. Several statistical methods can be applied to characterise 
the interpolation space, as described below. 
 
21. The simplest method for describing the AD is to consider the ranges of the individual 
descriptors. This approach is based on the assumption that the descriptor values follow a 
normal distribution, and could therefore be unreliable if this assumption is violated. A 
limitation of this approach is that the AD may include internal empty spaces, i.e. interpolation 
regions where the relationship is not proved (Figure 3.2). Another possible limitation is the 
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fact that intercorrelation between the descriptors is not taken into account, unless the 
individual descriptors are replaced by their principal components.  
 
 
 
Figure 3.2 
 
 
22. A more advanced method for defining the interpolation space of a model is to define 
the smallest convex area that contains the descriptors of the training set. However, this 
method does not solve completely the problem of empty spaces between the chemicals of the 
training set. In addition, for models that contain many descriptors, the calculation of the 
convex area becomes a time-consuming computational problem (see Figure 3.3). 
 
 
 
Figure 3.3 
 
23. A different approach to defining the AD is based on a calculation of the distance 
between a query chemical and a defined point in the descriptor space of the model (typically, 
the centroid of the training set). A detailed review of methods is given by Jaworska et al. (25). 
Different methods following this approach can be applied (e.g. Euclidean, Mahalanobis, 
Manhattan distance). The advantage of the distance (also called geometric) approach is that 
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confidence levels can be associated with the AD by drawing iso-distance contours in the 
interpolation space. The disadvantage is again the assumption of a normal distribution for the 
underlying data. This means that the contours are drawn solely on the basis of the distance 
from the centroid, and the population of the regions between two iso-distance contours is not 
taken into account. 
 
24. A common approach to distance analysis is to use the Hotelling’s test and the 
associated leverage statistics. The leverage of a chemical provides a measure of the distance 
of the chemical from the centroid of its training set. Chemicals in the training set have 
leverage values between 0 and 1. A “warning leverage” (h*) is generally fixed at 3p/n, where 
n is the number of training chemicals, and p the number of descriptors plus one. A leverage 
value greater than the warning leverage is considered large. 
 
25. The leverage is a useful statistic in both QSAR development and application. During 
QSAR development, chemicals with high leverage unduly influence the regression parameters 
of the model, and yet do not appear as statistical outliers (the regression line is forced near the 
high leverage chemical). It may therefore be appropriate to exclude such chemicals from the 
training set. During the application of a QSAR, chemicals with high leverage are likely to be 
outside the descriptor space of the model, and therefore the predictions for such chemicals 
could be unreliable. The leverage approach is illustrated in Gramatica et al. (26) and Pavan et 
al. (27).  
 
26. As with all statistical methods based on physicochemical descriptors, the leverage 
approach needs to be applied with care. While the observation that a chemical has a large 
leverage indicates that it is outside the descriptor coverage of the model, a chemical with 
small leverage can also be outside the AD for other reasons (e.g. a presence of a toxicophore 
that is not present in the training set). The inability to discriminate unequivocally between 
chemicals that are inside and outside the AD is common to all statistical methods based on 
physicochemical descriptors, and this should be taken into account when applying the concept 
of the AD.  
 
27. To visualise the outliers in a model, i.e. outliers in both the descriptor space and the 
response space, a plot of standardised residuals (R) vs leverages (or hat values, h), called the 
Williams graph is sometimes used. An illustration of the Williams plot, taken from Pavan et 
al. (27), is given in Figure 3.4a. This shows the training set of 86 chemicals for a polar 
narcosis model of acute toxicity to the fathead minnow (Verhaar et al., 20) as well as a test set 
of 8 chemicals for which the model was used to make predictions. It can be seen that 6 
chemicals in the training set have leverages greater than the warning leverage (0.07), as do 2 
of the test chemicals. The corresponding regression line for the model is shown in Figure 
3.4b. 
 
28. The most advanced statistical methods that are currently applied for identifying the 
(Q)SAR AD are probability density distribution-based methods. The probability density 
function of a data set can be estimated by parametric and non-parametric methods. The 
parametric methods assume a standard distribution (e.g. Gaussian or Poisson distribution) 
while the non-parametric methods (e.g. kernel density estimation function) make no 
assumptions about the data distribution. An advantage of non-parametric methods is the 
ability to identify internal empty spaces and, if necessary, to generate concave regions around 
the borders of the interpolation space to reflect the actual data distribution. It has been argued 
that the probability density approach is more robust than the range, distance and leverage 
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approaches (28). However, it is also more restrictive in terms of the chemical space that falls 
in the AD of a model. 
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Figure 3.4a 
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Figure 3.4b 
 
 
29. While some of the described statistical methods are available in a standard statistical 
packages (e.g. MINITAB, STATISTICA, SYSTAT), they are not adapted to meet the needs 
of (Q)SAR developers and users. In contrast, a user-friendly software package called Ambit 
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Disclosure being developed under the auspices of CEFIC LRI can be used to calculate the 
interpolation space by knowing the values of the dependent (endpoint) and independent 
(descriptors) variables used in a given model. The AD methods incorporated in the software 
are independent of the modelling technique and require only transparency of the training set. 
A free download is available on the internet (29). 
 
30. Ideally, the coverage of the training set should be accompanied by information on the 
structural or physicochemical similarity between the query molecule and the (Q)SAR training 
set. The similarity can be expressed in a qualitative or quantitative manner. Preferably, some 
mechanistic rationale should be given of whether the query chemical represents a mechanism 
common to a group of chemicals in the (Q)SAR training set. However, when such an 
assessment is not possible, a statistical expression of similarity can be obtained. 
 
31. One possible approach is to split the query molecule in fragments and to check 
whether all the fragments are represented in the training set of the model. The higher the 
occurrence of the query fragments in the training set, the higher the confidence that the quiery 
chemical of interest can be predicted reliably. This approach is adopted in the MultiCASE 
software and in the Leadscope platform (Leadscope Inc.). These programs issue a warning 
message that a chemical is outside of the AD of the model if encounters an unknown 
fragment. 
 
32. A quantitative expression of similarity can be obtained by calculating the Tanimoto 
coefficient. The Tanimoto coefficient is the ratio of shared substructures to the number of all 
substructures that appear in the reference chemical in the training set. The Tanimoto 
coefficient varies between 0 (total lack of similarity) to 1 (the query chemical has an identical 
constitution to the reference chemical). It is important to remember that the Tanimoto 
coefficient does not provide a unique measure of similarity - its meaning is based on how 
structural fragments are defined for the purposes of the comparison. Thus, two chemicals that 
are similar with a Tanimoto coefficient of 0.8 on the basis of one set of fragments may not be 
similar when compared by using a different set of fragments. Algorithms for calculating 
Tanimoto similarity coefficients are incorporated in several software products, including 
Ambit disclosure software and the Leadscope platform. 
 
33. A different approach needs to be adopted if multiple (Q)SAR models are being used 
for the prediction of the same endpoint. Theoretically, different models have different ADs. If 
a query chemical falls within the intersection of the ADs of the different models, the 
confidence of the overall prediction after combining (by averaging or other transformation) 
the individual predictions should be greater than the confidence associated with the prediction 
of a single model. However, it is expected that the common AD will be narrower for multiple 
models, thus restricting the number of potential chemicals that could be predicted. An 
example of the use of multiple models is provided by Tong et al. (30), who used a decision 
forest (i.e. multiple comparable and heterogeneous decision trees).  
 
34. Recently, a stepwise approach for determining the model AD has been proposed by 
Dimitrov et al. (31). It consists of four stages. The first stage identifies whether a chemical 
falls in the range of variation of physicochemical properties of the model. The second step 
defines the structural similarity between the query chemical and chemicals correctly predicted 
by the model. The third stage comprises a mechanistic check by assessing whether the 
chemical contains the specific reactive groups hypothesised to cause the effect. The fourth 
and final stage is a metabolic check, based on an assessment of the probability that the 
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chemical undergoes metabolic activation. The four stages are applied in a sequential manner. 
The advantage of processing query chemicals through all four stages is the increased 
reliability of prediction for those chemicals that satisfy to all four conditions for inclusion in 
the AD. The cost of applying this rigorous, multiple AD approach is that the number of 
chemicals for which reliable predictions are eventually made is reduced compared to the use 
of a single AD method.  
 
Comparing applicability domains with the spaces of regulatory inventories 
 
35. Defining the AD of a model not only provides a means of increasing the confidence 
associated with predictions inside the domain, but also of assessing the applicability of the 
model to a given regulatory inventory of chemicals. A model that gives highly accurate 
predictions for narrow chemical classes that are not covered by the regulatory inventory of 
interest would be of questionable value. A number of investigations have addressed the need 
to screen and prioritise chemical inventories established under different legislations in OECD 
Member Countries (32, 33, 34). Among the most commonly screened regulatory inventories 
are those of the High Production Volume Chemicals, Existing Substances, and inventories of 
pesticides and biocides. Less information is publically available regarding the inventories of 
New Substances, mainly because of confidentiality considerations. In addition, these 
inventories are periodically updated with new chemicals, which implies the need for iterative 
development of (Q)SAR models (35, 36) to expand their domains and adapt them to the 
regulatory domains of concern. An approach for comparing the AD with a regulatory domain 
is illustrated in a study (37) in which the AD of a QSAR for estrogenic potential is compared 
with the domain of the EINECS inventory (the list of Existing Substances in the EU). In this 
study, the physicochemical space of the EINECS inventory is characterised by using the 
descriptors in the QSAR model. 
 
Concluding remarks 
 
36. The third OECD principle on the need for a defined AD should be considered in 
combination with the fourth OECD principle on the need to characterise the statistical validity 
of a model, since an understanding of the AD can increase or decrease the confidence in a 
given (Q)SAR estimate. It should be noted, however, that the use of AD methods will never 
provide absolute certainty in the (Q)SAR estimates: a query chemical may appear to be within 
the defined AD, and yet the prediction could still be unreliable; conversely, the query 
chemical may appear to be outside the defined AD, and yet the prediction could be reliable. 
 
37. The model user should therefore be aware that AD methods, like other (statistical) 
methods discussed in this Guidance Document, provide a useful means of supporting 
decisions based on the additional use of expert judgement, but they cannot in themselves 
make the decisions. 
  
38. Numerous AD methods have been proposed based on the following considerations: 
structural features, physicochemical descriptor values, response values, mechanistic 
understanding, and metabolism.  On this basis, it is useful to conceptualise the AD of a model 
as the combination of one or more elements relating to the structural, physicochemical, 
response, mechanistic and metabolic domains. While these different types of domains provide 
useful distinctions, they should not be assumed to be mutually exclusive. For example, the 
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structural fragments present in a molecule will affect its physicochemical descriptors, its 
response value, and its mechanistic behaviour.  
 
39. The different AD methods should not be seen as in competition with one another, 
since the combined use of multiple AD methods should give a higher assurance that query 
chemicals are predicted accurately by a (Q)SAR model. Inevitably, there is a trade-off 
between the breadth of applicability of a model and the reliability of the predictions within the 
domain: the broader the scope of the model, the lower the overall reliability of prediction. The 
user of a model therefore needs to strike an appropriate balance between the level of 
confidence in the predictions resulting from AD considerations and the number of reliable 
predictions that are determined. 
 
40. Attempts to formalise and quantify the concept of the AD are relatively recent, which 
means that it is still a difficult concept to apply in regulatory practice. Thus, a considerable 
amount of research and development is still needed to further develop AD methods, as well as 
an understanding of the applicability of these methods. For example, the following research 
needs can be identified: 
 
a) the development of confidence limits associated with the AD; 
b) the development of AD methods for structural alerts and fragment-based QSAR 
methods; 
c) the assessment of AD methods with a view to better understand their strengths, 
limitations and applicabilities; 
d) the development of automated tools that facilitate the application of AD methods in an 
integrated manner with traditional statistical methods. 
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CHAPTER 4:  STATISTICAL VALIDATION  
 
Summary of chapter 4  
 
This chapter provides guidance on how to interpret OECD validation principle 4 that “a 
(Q)SAR should be associated with appropriate measures of goodness-of–fit, robustness and 
predictivity”. This principle expresses the need to perform statistical validation to establish 
the performance of the model, which consists of internal model performance (goodness-of- fit 
and robustness) and external model performance (predictivity), taking into account any 
knowledge about the applicability domain of the model (Chapter 3). The chapter starts with a 
brief introduction to principle 4 and statistical validation (1-4), followed by an explanation of 
some key terms and concepts (5-10). In paras 11-76, commonly used techniques for model 
development are then described and illustrated (multiple linear regression, partial least 
squares, classification modelling, neural network modeling) along with well-established 
statistical validation techniques for assessing goodness-of-fit, robustness and predictivity 
(cross-validation, bootstrapping, response randomisation test, training/test splitting, external 
validation). In the context of these different techniques, the statistics that are commonly used 
to describe model performance are explained. 
 
Introduction  
 
1. The regulatory acceptance and use of (Q)SAR models depends partly on what is 
known about their statistical performance. The need for information on model performance is 
expressed by OECD validation principle 4, according to which models should be associated 
with appropriate measures of goodness-of–fit and robustness (internal performance) and 
predictivity (external performance).  The assessment of model performance is sometimes 
called statistical validation. 
 
2. Statistical validation techniques are used during (Q)SAR development to find a 
suitable balance between two extremes: overfitted and underfitted models. The optimal model 
complexity is a trade-off between models that are “too simple” and therefore lacking in useful 
information and models that are too “complex” and therefore modelling noise (38,39). 
Statistical validation techniques provide various “fitness” functions that can be used by the 
QSAR practitioner to compare the quality of different models, and to avoid models that are 
too simplistic or too complex.  
 
3. Statistical validation techniques also provide a means of identifying “spurious” models 
based on chance correlations, i.e. situations in which an apparent relationship is established 
between the predictor and response variables, but which is not meaningful and not predictive 
(40,41,42). 
 
4. The statistical validation techniques described in this chapter should be considered in 
combination with any knowledge about the applicability domain (AD) of the model, since the 
choice of chemicals during model development and validation affects the assessment of 
performance. In particular, chemicals that are outside the AD during model development may 
unduly influence the regression parameters of the model, thereby affecting its robustness. 
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Chemicals that are outside the AD during model validation are unlikely to be predicted with 
the desired level of reliability. 
 
 
Basic concepts  
5. This  section provides an explanation of some key concepts that are needed to 
understand the remainder of the chapter.  
 
6. The QSAR modelling process starts with the compilation of a data set which is often 
divided into a training set, used to derive the model through the application of a statistical 
method, and a test set, containing chemicals not used in the derivation of the model. The 
variables in the model are chosen to optimise model complexity, and are referred to as 
predictors. In QSAR modelling, the predictors are (molecular) descriptors. 
 
7. The model derived from the training set is used to predict of the response data in both 
the training and the test sets. The accuracy of prediction for a given chemical is the closeness 
of an estimate/prediction to a reference value. The greater the proportion of accurate 
predictions, the more reliable the model.  
 
8. Predictions for chemicals in the training set are used to assess the goodness-of-fit of 
the model, which is a measure of how well the model accounts for the variance of the 
response in the training set. The generation of predictions within the range of predictor values 
in the training set is called interpolation, whereas extrapolation is the generation of a 
prediction outside the range of values of the predictor in the sample used to generate the 
model. The more removed the predicted value from the range of values used to fit the model, 
the more unreliable the prediction becomes, because it is not certain whether the model 
continues to hold. 
 
9. The robustness of model refers to the stability of its parameters (predictor coefficients) 
and consequently the stability of its predictions when a perturbation (deletion of one or more 
chemicals) is applied to the training set, and the model is regenerated from the “perturbed” 
training set. 
 
10. Predictions for chemicals in the test set are used to assess the predictive ability of the 
model, which is a measure of how well the model can predict of new data, which not used in 
model development. In this document, predictive ability is used synonymously with 
predictive capacity, predictive power and predictivity.  
 
 
Recommendations for practitioners  
 
Multiple Linear Regression (MLR) 
 
11. Multiple linear regression (MLR) is the traditional statistical approach for deriving 
QSAR models. It relates the dependent variable y (biological activity) to a number of 
independent (predictor) variables xi (molecular descriptors) by using linear equations (Eq. 1, 
Table 4.1). 
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12. Estimating the regression coefficients. Regression coefficients bj in MLR model can 
be estimated using the least squares procedure by minimizing the sum of the squared 
residuals. The aim of this procedure is to give the smallest possible sum of squared 
differences between the true dependent variable values and the values calculated by the 
regression model.  
 
13. Assessing the relative importance of descriptors . If the variables are standardized to 
have mean of zero and standard deviation of one, then the regression coefficients in the model 
are called beta coefficients. The advantage of beta coefficients (as compared to regression 
coefficients that are not standardised) is that the magnitude of these beta coefficients allows 
the comparison of the relative contribution of each independent variable in the prediction of 
the dependent variable. Thus, independent variables with higher absolute value of their beta 
coefficients explain greater part from the variance of the dependent variable. 
 
Measures of goodness-of-fit in Multiple Linear Regression  
 
14. Assessing goodness-of-fit. To assess goodness-of-fit, the coefficient of multiple 
determination (R2) is used (Eq. 2, Table 4.1). R2 estimates the proportion of the variation of y 
that is explained by the regression (43). If there is no linear relationship between the 
dependent and the independent variables R2= 0; if there is a perfect fit R2= 1. R2 value higher 
than 0.5 means that the explained variance by the model is higher than the unexplained one. 
The end-user(s) of a QSAR model should decide what value of R2 is sufficient for the specific 
application of the model. One author has recommended that R = 0.9 for in vitro data and R = 
0.8 for in vivo data can be regarded as good (44).  
 
15. Avoiding overfitting. The value of R2 can generally be increased by adding additional 
predictor variables to the model, even if the added variable does not contribute to reduce the 
unexplained variance of the dependent variable. It follows that R2 should be used with 
caution. This could be avoided by using another statistical parameter – the so-called adjusted 
R2 (R2adj) (Eq. 3, Table 4.1). R2adj is interpreted similarly to the R2 value except it takes into 
consideration the number of degrees of freedom. It is adjusted by dividing the residual sum of 
squares and total sum of squares by their respective degrees of freedom. The value of R2adj 
decreases if an added variable to the equation does not reduce the unexplained variance. 
 
16. From the calculated and observed dependent variable values the standard error of 
estimate s could be obtained (Eq. 4, Table 4.1). The standard error of estimate measures the 
dispersion of the observed va lues about the regression line. The smaller the value of s means 
higher reliability of the prediction. However it is not recommended to have standard error of 
estimate smaller than the experimental error of the biological data, because it is an indication 
for an overfitted model (44). 
 
17. The statistical significance of the regression model can be assessed by means of F-
value (Eq. 5, Table 4.1). The F-value is the ratio between explained and unexplained variance 
for a given number of degrees of freedom. The higher the F-value the greater the probability 
is that the equation is significant. The regression equation is considered to be statistically 
significant if the observed F-value is greater than a tabulated value for the chosen level of 
significance (typically, the 95% level) and the corresponding degrees of freedom of F. The 
degrees of freedom of F-value are equal to p and n-p-1. Significance of the equation at the 
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95% level means that there is only a 5% probability that the dependence found is obtained due 
to chance correlations between the variables. 
 
18. The statistical significance of the regression coefficients can be obtained from a t-test 
(Eq. 6, Table 4.1). It is used to test the hypothesis that the regression coefficient is zero. If the 
hypothesis is true, than the predictor variable does not contribute to explain the dependent 
variable. Higher t-values of a regression coefficient correspond to a greater statistical 
significance. The statistical significance of a regression coefficient using its t-value is 
determined again from tables for a given level of significance (similar to the use of F-value). 
The degrees of freedom of t are equal to n-p-1 (corresponding to the degrees of freedom of the 
residual mean square). Statistical significance at the 95% level means there is only a 5% 
probability that the regression coefficient of a given variable is not significantly different from 
zero. The t-values are used to calculate the confidence intervals for the true regression 
parameters. These confidence intervals can also be used to check the significance of the 
corresponding regression coefficients. In practice the confidential intervals should be smaller 
than the absolute values of the regression coefficients in order to have statistically significant 
independent variables (Error! Reference source not found.).  
 
Partial Least Squares regression (PLS) 
 
19. Partial Least Squares (PLS), introduced by Wold et al. (45, 46), is a MLR method that 
allows relationships to be sought between an X-block of p predictors and a single y response 
(PLS1) or a Y-block of r responses (PLS2). Thus several activity variables, Y, i.e. profiles of 
activity, can be modelled simultaneously. An advantage of PLS is that it tolerates a certain 
amount of missing data. For instance, in the case of data set containing 20 compounds, 10-
20% missing data can be tolerated (47). 
 
20. Information provided by PLS. The purpose of PLS is to find a small number of 
relevant factors (A) that are predictive of Y and utilize X efficiently (48). The PLS model is 
expressed by a matrix of scores (T) that summarizes the X variables, a matrix of scores (U) 
that summarizes the Y variables, a matrix of weights (W) expressing the correlation between 
X and U(Y), a matrix of weights (C) expressing the correlation between Y and T(X), and a 
matrix of residuals (the part of data that are not explained by the model). For the interpretation 
of the PLS model a number of informative parameters can be used. The scores t and u contain 
information about the compounds and their similarities/dissimilarities with respect to the 
given problem. The weights w and c provide information about how the variables can be 
combined to form a quantitative relation between X and Y. Hence they are essential for 
understanding which X variables are important and which X variables provide the same 
information. The residuals are of diagnostic interest – large residuals of Y indicate that the 
model is poor and the outliers should be identified (47). PLS regression coefficients can be 
obtained after re-expression of the PLS solution as a regression model. When X values are 
scaled and centered and Y values are scaled, the resulting coefficients are useful for 
interpreting the influence of the variables X on Y (49, 50). 
 
Measures of goodness-of-fit in Partial Least Squares regression 
 
21. The quantitative measure of the goodness of fit is given by the parameter R2 (= the 
explained variation) analogous to MLR. PLS model is characterized by the following R2 
parameters: 
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· R2(Y) – cumulative sum of squares of all dependent values (Y) explained by all 
extracted components 
· R2(X) – cumulative sum of squares of all descriptor values (X) explained by all 
extracted components 
· R2(Y)adj, R2(X)adj – cumulative R2(Y) and R2(X) respectively adjusted for the degrees 
of freedom 
 
22. Avoiding overfitting. Depending on the number of components, near perfect 
correlations are often obtained in PLS analysis, due to the usually large number of included X 
variables. Therefore, the high R2(Y) is not a sufficient criterion for the validity of a PLS 
model. A cross-validation procedure must be used and Q2(Y) parameter must be calculated to 
select the model having the highest predictive ability (44). In contrast to R2(Y), Q2(Y) does 
not increase after a certain degree of model complexity. Hence, there is a zone, where there is 
a balance between predictive power and reasonable fit (48). According to the proposed 
reference criteria the difference between R2(Y) and Q2(Y) should not exceed 0.3. A 
substantially larger difference is indication for an overfitted model, presence of irrelevant X-
values or outliers in the data (51). 
 
23. Identification of outliers . As a measure of the statistical fit of the PLS model also the 
residual standard deviation (RSD) can be used, which corresponds to the standard deviation in 
the MLR. It should be similar in size to the known or expected noise in the system under 
investigation. The RSD can be calculated for the responses and predictor variables. The RSD 
of an X variable is indication for its relevance to the PLS model. The RSD of a Y variable is a 
measure of how well this response is explained by the PLS model. The RSD of an observation 
in the X or Y space is proportional to the observation distance in the hyper plane of the PLS-
model in the corresponding space (DModX and DModY). The last ones give an information 
about the outliers in X- and Y-data (48, 50). 
 
Classification Models (CMs) 
 
24. Chemicals are sometimes classified into two (e.g. active/inactive) or more pre-defined 
categories, for scientific or regulatory purposes. For scientifc purposes, the biological 
variability of certain endpoints is sometimes too large to enable reasonable quantitative 
predictions, so that the data is converted into one or more categories of toxic effect. 
Otherwise, in regulatory toxicology, binary classification systems are commonly used to 
provide a convenient means of labelling chemicals, according to their hazard.  
 
25. Classification-based QSARs, also referred as classification models (CMs), can be 
developed using a variety of statistical methods. Among the methods appropriate for the 
development of linear CMs, multivariate discriminant analysis (MDA), logistic regression 
(LR), and decision or classification trees (CT), among others, have been extensively described 
in the literature (52). Also, rule-based models expressed in symbolic “if… then” decision 
rules, can be derived from the CMs. For the models associated with non- linear boundaries, 
embedded cluster modelling (ECM) (53), neural networks (NN), and k-nearest neighbour (k-
NN) classifiers can be used.  
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Measures of goodness-of-fit in classification models 
 
26. The goodness-of-fit of a CM can be assessed in terms of its Cooper statistics, which 
were introduced in the late seventies to describe the validity of carcinogen screening tests 
(54Error! Reference source not found.). Cooper statistics, based on a Bayesian approach 
(55, 56) has been extensively applied to assess the results of classification (Q)SAR models 
(51, 57). Bayesian-based methods can also be used to combine results from different cases, so 
that judgments are rarely based only on the results of a single study but they rather synthesize 
evidence from multiple sources. These methods can be developed in an iterative manner, so 
that they allow successive updating of battery interpretation.  
 
27. In a CM, the results of the classification can be arranged in the so-called confusion or 
contingency matrix (58), where the rows represent the reference classes (Ag), while the 
columns represent the predicted classes assigned by the CM (Ag’). Table 4.2 illustrates the 
general form of a contingency matrix for the general case of G classes. 
 
28. Interpreting the contingency matrix. The main diagonal (cgg’) represents the cases 
where the true class coincides with the assigned class, that is, the number of objects correctly 
classified in each class, while the non-diagonal cells represent the misclassifications. 
Overpredictions are to the right and above the diagonal, whereas underpredictions are to the 
left and below the diagonal. The right-hand column reports the number of objects belonging 
to each class (ng), whereas the bottom row reports the total number of objects assigned to each 
class according to the CM (ng'). 
 
29. Setting the importance of misclassifications . Depending on the intended use of the 
CM, some classification errors may be considered “worse” than others. In order to quantify 
such error, the loss matrix (L), which the same structure as the contingency matrix, can be 
used (Table 4.3). It can be considered as a matrix of weights for the different types of 
classification errors, where the non-diagonal elements quantify the type of error in the 
classification.  
 
30. According to this matrix of weights, the classification errors that for example confuse 
class A1 with class A3 and class AG are more significant (loss value of 2) than the ones than 
confuse class A1 with class A2 (loss value of 1). The main diagonal corresponds to the correct 
classification, so that the loss value is set to zero. This matrix can be defined in an arbitrary 
way, according to the situation. If it is not explicit all the errors can be assigned to have the 
same weight of 1.  
 
31. The most commonly used goodness-of-fit parameters for a CM are defined in Table 
4.4. When evaluating the results of a CM, the reference situation is generally taken to be the 
one  in which all of the objects are assigned to the class that is most represented, which. This 
reference condition corresponds to the absence of a model, and is therefore called the No-
Model. Goodness-of- fit values close to the ones of the No-Model condition give evidence of a 
poor result of the classification method. The No-Model value is unique and independent from 
the classification method adopted. Other statistics have been proposed, like kappa (k) statistic 
(59Error! Reference source not found.). 
 
32. In the particular case of a two-group CM, which evaluates the presence or absence of 
activity, Cooper statistics can be calculated from a 2x2 contingency table (see Table 4.5).  
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33. The statistics in Table 4.6 collectively express the performance of a CM, provided 
they measure its ability to detect known active compounds (sensitivity), non-active 
compounds (specificity), and all chemicals in general (concordance or accuracy). The false 
positive and false negative rates can be calculated from the complement of specificity and 
sensitivity, respectively. The positive and negative “predictivities” focus on the effects of 
individual chemicals, since they act as conditional probabilities. Thus, the positive 
“predictivity” is the probability that a chemical classified as active is really active, while the 
negative “predictivity” gives the probability that a classified non-active chemical is really 
non-active.  
 
34. A high value of sensitivity is usually associated with a high false positive rate, so that 
the CM is good at identifying known active compounds, but this is at the expense of over-
classifying known non-active compounds. The same relationship holds for the specificity and 
the rate of false negatives. Given a fixed sensitivity and specificity, the positive and negative 
predictivities vary according to the prevalence or proportion of active chemicals in a 
population, i.e. (a+b)/N. Furthermore, the accuracy is influenced by the performance of the 
most numerous class. Therefore, CMs should not be judged according to these statistics alone. 
 
35. For the assessment of the predictive performance of two-group CMs, the maximal 
classification performance achievable should be assessed on the basis of the quality of the 
predictor and response data and taking also into account the purpose of the model. Thus, for 
stand-alone classification models, the Cooper statistics should be significantly greater than 
50%, whereas for a CM that identifies active or inactive chemicals in a battery of models, a 
lower performance could still be useful.  
            
36. The classification ability of a CM depends on the particular data set of chemicals used. 
It is therefore useful to report some measure of the variability associated with the 
classifications. This indicates whether the classification performance of the CM would vary 
significantly if it had been assessed with a different set of chemicals. To estimate the 
confidence intervals (CI) for the Cooper statistics, the bootstrap re-sampling technique can be 
used (60, 61).  
 
37. To compare the performances of a number of classification models, the Receiver 
Operating Characteristic (ROC) curve can be used. ROC curves are so-named because they 
were first used for the detection of radio signals in the presence of noise in the 1940s (62). In 
the ROC graph, the X-axis is 1-specificity (false positive rate) and the Y-axis is the sensitivity 
(true positive rate). The best possible CM would yield a point located in the upper left corner 
of the ROC space, i.e. high true positive rate and low false positive rate. A CM with no 
discriminating power would give a straight line at an angle of 45 degrees from the horizontal, 
i.e. equal rates of true and false positives (63, 64). An index of the goodness of the CM is the 
area under the curve: a perfect CM has area of 1.0, whilst a non-discriminating test (one 
which falls on the diagonal) has an area of 0.5. 
 
38. In the case of a CM based on continuous predictors, the ROC curve allows us to 
explore the relationship between the sensitivity and specificity resulting from different 
thresholds (cut points), thus allowing an optimal threshold to be determined (Figure 4.1). The 
threshold is an arbitrary cut-off value that determines when the prediction is considered as 
positive or negative. Ideally, both sensitivity and specificity would be equal to one, but 
changing the threshold to increase one statistic usually results in a decrease in the other. 
Points greater than the threshold are classified positive, whereas points less than the threshold 
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are classified negative. If the threshold is increased, the false positive rate decreases. 
However, as the false positive rate decreases, the true positive rate also decreases; this 
corresponds to points in the bottom left of the ROC curve. Otherwise, if the threshold is 
decreased, the proportion of true positives (Y axis) increases, rather dramatically initially, and 
then more gradually; this corresponds to points in the top right of the ROC curve. 
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Figure 4.1 ROC curve for a model producing a continuous output. The coordinates are 
indicative of the performance of the models corresponding to: (0,0) high threshold, (1,1) low 
threshold, (0,1) perfect classification, y=x, model with no discriminatory power.   
 
39. Setting the importance of misclassifications . The assessment of classification 
accuracy often assumes equal costs of false positives and false negative errors. However, in 
real applications, the minimisation of costs should be considered alongside the maximization 
of accuracy. The problems of unequal error costs and uneven class distributions are rela ted, so 
that high-cost cases can be compensated by modifying their prevalence in the set (65).  
 
40. The robustness of a CM can be evaluated by the total number of misclassifications, 
estimated with the leave-one-out method (66). Alternatively, the above-mentioned set of 
optimal loss factors (i.e. weights for different kinds of misclassifications that are minimised in 
the process of fitting a model) can be defined to reflect that some classification errors are 
more detrimental than others. The loss function represents a selected measure of the 
discrepancy between the observed data and data predicted by the fitted function. It can be 
empirically estimated and employed in a minimum risk decision rule rather than a minimum 
error probability rule. Also, by combining different predictions, the resulting models are more 
robust and accurate than single model solutions. 
 
Artificial Neural Networks (ANNs) 
 
41. An Artificial Neural Network (ANN) is a mathematical model that “learns” from data 
in a manner that emulates the learning pattern in the human brain. The calculations in a neural 
network model occurs as a result of the “activation” of a series of neurons, which are situated 
in different layers, from the input layer through one or more hidden layers to the output layer. 
The neural network learns by repeatedly passing through the data and adjusting its connection 
weights to minimise the error.  
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42. There are two main groups of ANN, which differ in architecture and in learning 
strategy: (i) unsupervised and supervised self orga nizing maps; and (ii) supervised back-
propagation ANN (67). The terms “unsupervised” and “supervised” indicate whether only 
descriptors (input variables), or both descriptors and biological activities (output variables), 
participate in the training of ANN. 
  
43. ANNs are especially suitable for modelling non-linear relationships and trends and 
have been used to tackle a variety of mathematical problems, including data exploration, 
pattern recognition, the modelling of continuous and categorized responses, and the modelling 
of multiple responses (68, 69), the classification of objects toxicological classes or modes of 
toxic action (71), selection of relevant descriptors, and division of the original data set into 
clusters (72). 
 
Measures of goodness-of-fit in neural networks 
 
44. Several tests for assessing the goodness-of-fit of NN models (based on the training 
set) are recommended. In the recall ability test (73, 74, 75, 76), the activity values are 
calculated for the objects of training set, to provide an indication of how well the model 
recognises the objects of training set. The test results are usually reported as the standard 
deviation and the parameters of the regression line between reference values and predicted 
values. Since the recall ability test is a test for goodness-of- fit only, it is recommended 
additional tests are also used, such as leave-one-out, leave-many-out, Y-Scrambling, and 
assessment with independent test set. 
 
Measures of robustness 
 
45. The aim of validation techniques is thus to find a model which represents the best 
trade-off between the model simplicity and its variability, in order to minimize the Mean 
Squared Error (MSE) (Table 4.7), minimising the bias as well as the unexplained variance. 
 
46. A necessary condition for the validity of a regression model is that the multiple 
correlation coefficient R2 is as close as possible to one and the standard error of the estimate s 
small. However, this condition (fitting ability), which measures how well the model is able to 
mathematically reproduce the end point data of the training set, is an insufficient condition for 
model validity. In fact, models that give a high fit (smaller s and larger R2) tend to have a 
large number of predictor variables (51). These parameters are measures of the quality of the 
fit between predicted and experimental values, and do not express the ability of the model to 
make reliable predictions on new data.  
 
47. It is well known that increasing the model complexity always increases the multiple 
correlation coefficient (R2), i.e. the explained variance in fitting, but if model complexity is 
not well supervised then the predictive power of the model, i.e. the explained variance in 
prediction (Q2) decreases. The differing trends of R2 and Q2 with an increasing number of 
predictor variables is illustrated in Figure 2.  
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Figure 4.2. Comparison of the explained variance in fitting with the explained variance in 
prediction.  
 
48. In Figure 4.2, it can be seen that increasing the number of predictors improves the 
explained variance in fitting (R2). On the other hand, the explained variance in prediction (Q2) 
only up to 5 predictors (which represents the maximum predictive power in this case) but 
adding further statistically insignificant predictors decreases the model performance in 
prediction. 
 
49. The first condition for model validity deals with the ratio of the number of objects (i.e. 
chemicals) over the number of selected variables. This is called the Topliss ratio. As a rule-of-
thumb, it is recommended that the Topliss ratio should have a value of at least 5. 
 
50. The quality of multivariate regression models is usually evaluated by different fitness 
functions (e.g. adjusted R2, Q2) (Table 4.7) able to find the optimal model complexity and 
useful to compare the quality of different QSAR models.  
 
51. For this reason, the structure of a QSAR model (number of predictors, number of PCs, 
number of classes) should always be inspected by validation techniques, able to detect 
overfitting due to variable multicollinearity, noise, sample specificity, and unjustified model 
complexity. 
 
52. Model validation can be performed by internal validation techniques and external 
validation techniques. As illustrated in Figure 4.3, in case of internal validation a number of 
modified data sets are created by dele ting, in each case, one or a small group of objects and 
each reduced data set is used to estimate the predictive capability of the final model built by 
using the whole data set. This means that the model predictivity is estimated by compounds 
(the test set) that took part in the model development, thus the information of these 
compounds is included in the final model. On the other hand a more demanding evaluation is 
the one provided by an external validation where the model predictivity is estimated by new 
experimentally tested compounds (external test set) that did not take part in the model 
development. 
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Figure 4.3. Internal and external validation. 
 
53. A number of internal validation techniques can be used to simulate the predictive 
ability of a model (77, 78). The most popular validation ones are listed below: 
·  Cross validation (leave-one-out (LOO) and leave-many-out (LMO)). 
·  Bootstrapping 
·  Y-scrambling or response permutation testing 
·  Training/test set splitting 
 
54. Cross validation is the most common validation technique where a number of 
modified data sets are created by deleting, in each case, one or a small group of compounds 
from the data in such a way that each object is removed away once and only once. From the 
original data set, a reduced data set (training set) is used to develop a partial model, while the 
remaining data (test set) are used to evaluate the model predictivity (79, 80). For each reduced 
data set, the model is calculated and responses for the deleted compounds are predicted from 
the model. The squared differences between the true response and the predicted response for 
each compound left out are added to the predictive residual sum of squares (PRESS). From 
the final predictive residual sum of squares, the Q2 (or R2CV) and SDEP (standard deviation 
error of prediction) values are calculated (81) (Table 4.7). 
 
55. The simplest cross validation procedure is the leave-one-out (LOO) technique, where 
each compound is removed, one at a time. In this case, given n compounds, n reduced models 
are calculated, each of these models is developed with the remaining n-1 compounds and used 
to predict the response of the deleted compound. The model predictive power is then 
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calculated as the sum of squared differences between the observed and estimated response. 
This technique is particularly important as this deletion scheme is unique and the predictive 
ability of the different models can be compared accurately. However, the predictive ability 
obtained is often too optimistic, particularly with larger datasets compounds, because the 
perturbation in the dataset is small and often insignificant when only one compound is 
omitted. 
 
56. To obtain more realistic estimates of the predictive ability, it is often necessary to 
remove more than one compound at each step. In the leave-many-out (LMO) cross-validation 
procedure, the data set is divided into a number of blocks (cancellation groups) defined by the 
user. At each step, all the compounds belonging to a block are left out from the derivation of 
the model. The cancellation groups G range from 2 to n. For example, given 120 compounds 
(n = 120), for 2, 3, 5, 10 cancellation groups G, at each time m (= n/G) objects are left in the 
test sets, i.e. 60, 40, 24, and 12 compounds, respectively. Rules for selecting the group of 
compounds for the test set at each step must be adopted in order to leave out each compound 
only one time. The LOO method is equivalent to a LMO method with G = n, i.e. with a 
number of cancellation groups equal to the number of compounds. By introducing a larger 
perturbation in the data set, the predictive ability estimated by LMO is more realistic than the 
one by LOO.  
 
57. Bootstrap resampling is another technique to perform internal validation (60Error! 
Reference source not found.). The basic premise of bootstrap resampling is that the data set 
should be representative of the population from which it was drawn. Since there is only one 
data set, bootstrapping simulates what would happen if the samples were selected randomly. 
In a typical bootstrap validation, K groups of size n are generated by a repeated random 
selection of n compounds from the original data set. Some of these compounds can be 
included in the same random sample several times, while other compounds will never be 
selected. In this validation technique, the original size of the data set (n) is preserved by the 
selection of n compounds with repetition. In this way, the training set usually consists of 
repeated compounds and the test set of the compounds left out (82). The model is derived by 
using the training set and responses are predicted by using the test set. All the squared 
differences between the true response and the predicted response of the compounds of the test 
set are expressed in the PRESS statistic. This procedure of building training sets and test sets 
is repeated thousands of times. As with the LMO technique, a high average Q2 in bootstrap 
validation is indicative of model robustness and what is sometimes referred to as “internal 
predictivity”.  
 
58. Y-scrambling or response permutation testing is another widely used technique to 
check the robustness of a QSAR model, and to identify models based on chance correlation, 
i.e. models where the independent variables are randomly correlated to the response variables. 
The test is performed by calculating the quality of the model (usually R2 or, better, Q2) 
randomly modifying the sequence of the response vector y, i.e. by assigning to each 
compound a response randomly selected from the true set of responses (83). If the original 
model has no chance correlation, there is a significant difference in the quality of the original 
model and that associated with a model obtained with random responses. The procedure is 
repeated several hundred of times. 
 
 
59. Models based on chance correlation can be detected by using the QUIK rule. Proposed 
in 1998 (84), the QUIK rule is a simple criterion that allows the rejection of models with high 
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predictor collinearity, which can lead to chance correlation (85). The QUIK rule is based on 
the K multivariate correlation index (Table 4.7) that measures the total correlation of a set of 
variables. The rule is derived from the evident assumption that the total correlation in the set 
given by the model predictors X plus the response Y (KXY) should always be greater than that 
measured only in the set of predictors (KX). Therefore, according to the QUIK rule only 
models with the KXY correlation among the [X + Y] variables greater than the KX correlation 
among the [X] variables can be accepted. The QUIK rule has been demonstrated to be very 
effective in avoiding models with multi-collinearity without prediction power.  
 
60. An example of the application of the QUIK rule in QSAR studies is provided (84) by a 
series of 11 3-quinuclidinyl benzylates represented by three physicochemical descriptors: 
Norrington’s lipophilic substituent constant pN (x1), its squared values p2N (x2), and the Taft 
steric constant Es (x3). The y response was the apparent equilibrium constant Kapp. This data 
set has been extensively discussed by Stone & Jonathan (86) and by Mager (87), who 
concluded that the model has multicollinearity without prediction power. The regression 
model obtained by Ordinary Least Squares regression (OLS) was: 
 
y = -8.40 + 8.35 x1 -1.70 x2 +1.43 x3       (Eq 1) 
 
with the following statistics:  
 
R2 = 91.8     Q2LOO = 81.5    Q2LMO = 67.0 
 
where R2, Q2LOO and Q2LMO are the explained variances in fitting, by leave-one-out cross 
validation and by leave-many-out cross validation (two objects left out at each step), 
respectively. The large decrease in the predictive performance of the model was already 
suspect. The same conclusions were reached applying the QUIK rule. In fact, for the proposed 
model, the K values were:  
 
Kxy = 47.91  <  Kx = 54.87 
 
According to the QUIK rule, the model would be rejected, the X correlation being greater than 
the X+Y- correlation. 
 
61. Another method to check chance correlation is to add a percentage of artificial noisy 
variables to the set of available variables. This approach allows the detection of optimal 
model size, i.e. the size  for which no noisy variable is present in models of this size and an 
example of its capability tested on a spectral matrix was extensively illustrated in Jouan-
Rimbaud et al. (38). In fact, when simulated noisy variables start to appear in the evolving 
model population it means that the allowed maximum model size can no longer be increased 
since optimal complexity has been reached. However, this approach does not account for the 
likely correlation between a generated noisy variable and the Y response. In fact, there is a 
high probability that on generating a number of noisy predictors some will be significantly 
correlated with the y response. While chance correlation is considered explicitly in the Y 
scrambling procedure, by response randomisation, a noisy predictor could play an important 
role in modelling in the latter approach, contributing in the same way as a true predictor with 
a small, but significant, correlation with response. For this reason, noisy variables should only 
be used if a check on their correlation with the y response is performed first, excluding all the 
noisy variables with correlation greater than a fixed threshold value (85). An optimal value of 
this threshold can be chosen only if the experimental error of the response is known a priori. 
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62. The training/test set splitting is a validation technique based on the splitting of the data 
set into a training set and an test set. The model is derived from the training set and the 
predictive power is estimated by applying the model to the test set. The splitting is performed 
by randomly selecting the objects belonging to the two sets. As the results are strongly 
dependent on the splitting of the data, this technique is better used by repeating the splitting 
several hundred of times and averaging the predictive capabilities, i.e. using the repeated test 
set technique (88).  
 
Measures of predictivity 
 
63. One of the most important characteristics of a (Q)SAR model is its predictive power, 
i.e. the ability of a model to predict accurately the (biological) activity of compounds that 
were not used for model development. While the internal validation techniques described 
above can be used to establish model robustness, they do not directly assess model 
predictivity.  
 
64. In principle, external validation is the only way to “determine” the true predictive 
power of a QSAR model. This type of assessment requires the use of an external test set, i.e. 
compounds not used for the model development. It is generally considered the most rigorous 
validation procedure, because the compounds in the external test set do not affect the model 
development. In fact, the test set is often constituted of new experimentally tested compounds 
used to check the predictive power of the model. 
 
65. External validation should be regarded as a supplementary procedure to internal 
validation, rather than as a (superior) alternative. This is because a model that is externally 
predictive should also be robust, although a robust model is not necessarily predictive (of 
independent data). Indeed, a high value of the leave-one-out cross-validated correlation 
coefficient, Q2, can be regarded as a necessary, but insufficient, condition for a model to have 
a high predictive power (89). 
 
66. The predictivity of a regression model is estimated by comparing the predicted and 
observed values of a sufficiently large and representative external test set of compounds that 
were not used in the model development. By using the selected model, the values of the 
response for the test objects are calculated and the quality of these predictions is defined in 
terms of external explained variance Q2ext (Table 4.7). Unlike the cross-validated correlation 
coefficient, Q2, in the external explained variance Q2ext the sum of the predictive residual 
sum of squares on the numerator runs over the external test chemicals and the reference total 
sum of squares on the denominator is calculated comparing the predicted response of the 
external test chemicals with the average response of the training set.  
 
67. Analogously, the predictivity of a classification model is estimated by comparing the 
predicted and observed classes of a sufficiently large and representative test set of compounds 
that were not used in the model development. The parameters described in Table 4.4, but 
derived by using the external test set, are used to quantify the CM predictivity. 
 
68. In practice, for reasons of cost, time and animal welfare, it is often difficult or 
impossible to obtain new experimentally tested compounds to check model predictivity, and 
for this reason a common practice is to split the available dataset into training set, used to 
develop the (Q)SAR model and an external test set, containing compounds not present in the 
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training set and used to assess the predictive capability of a (Q)SAR model. This technique 
can be used reliably only if the splitting is performed by partitioning the compounds 
according to a pre-defined and suitable criterion, such as a criterion based on experimental 
design or cluster analysis.  
 
69. When performing statistically designed external validation, the goal is to ensure that: 
a) the training and test sets separately span the whole descriptor space occupied by the entire 
data set; and b) the structural domains in the two sets are not too dissimilar. It is important 
that the training set contains compounds that are informative and good representatives of 
many other similar compounds. Thus, the following criteria were recently proposed for 
training and test selection (90): a) representative points of the test set must be close to points 
in of the training set; b) representative points of the training set must be close to points in the 
test set; and c) the training set must be diverse. These criteria were proposed to ensure that the 
similarity principle can be adopted when predicting the test set. 
 
70. To accomplish a well-planned selection, some approach to statistical experimental 
design is needed (91). An ideal splitting leads to a test set such that each of its members is 
close to at least one member of the training set (92). Developing rational approaches for the 
selection of training and test sets is an active area of research. These approaches range from 
the straightforward random selection (93) through activity sampling and various systematic 
clustering techniques (94, 95), to the methods of self-organising maps (96), Kennard Stone 
(97), formal statistical experimental design (factorial and D-Optimal) (98), and recently 
proposed modified sphere exclusion algorithm (99). These methods help achieve desirable 
statistical characteristics of the training and test sets. 
 
71. A frequently used approach is activity sampling (100), according to which the choice 
of training and test sets is made by binning the range of experimental values and randomly 
selecting an even distribution of compounds from each bin. This guarantees that members of 
the test set span the entire range of the experimental measurements and are numerically 
representative of the data set. However, because the binning is based on the response, it does 
not guarantee that the training set represents the entire descriptor space of the original dataset 
and that each compound of the test set is close to at least one of the training set. 
 
72. In several applications, the training/test splitting is performed by using clustering 
techniques. K-means algorithm is often used, and from each cluster one compound for the 
training set is randomly selected. Given that all compounds are represented in a 
multidimensional descriptor space, the clustering algorithm can be performed on the 
descriptor values (X values), on response values (Y values), or on the descriptor/response 
values (X/Y values). Clustering on X/Y values allows clustering the compounds according to 
all of the given information (101). An alternative clustering approach to select representative 
subset of compounds is the one based on the maximum dissimilarity method (94, 95). The 
method starts with the random selection of a seed compound, then every new compound is 
successively selected such that it is maximally dissimilar from all the other compounds of the 
dataset. The process ends either when a maximum number of compounds has been selected or 
when no other compound can be selected without being too similar to one already selected. 
Since this method is based on a random starting point, the variance of the results is normally 
checked by comparing various selections. Hierarchical clustering provides a more specific 
control by assigning every single compound to a cluster of compounds. It does not require any 
prior assumption about the number of clusters, and after the clustering process the compound 
closest to the centre of a cluster is selected as representative compound. 
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73. Another way to perform a statistically planned training/test selection is by using the 
Kohonen’s Self-Organising Maps (102). The main goal of the neural network is to map 
compounds from n-dimensional into two-dimensional space. Representative compounds 
falling in the same areas of the map are randomly selected for the training and test sets. This 
approach preserves the closeness between compounds: compounds which are similar in the 
original multidimensional space are close to each other on the map. 
 
74. Similarly to the maximum dissimilarity method, the Kennard Stone algorithm can be 
used to perform data splitting (103). It is sequential and consists in maximizing the Euclidean 
distances between the newly selected compounds and the ones already selected. An additional 
compound is selected by calculating for each compound, which is not selected, the distance to 
each selected compound and by maximizing the distance to the closest compound already 
selected. Both the maximum dissimilarity and the Kennard Stone methods guarantee that the 
training set compounds are distributed more or less evenly within the whole area of the 
representative points, and the condition of closeness of the test set to the training set is 
satisfied. 
 
75. Another data splitting strategy makes use of fractional factorial design (FFD) and D-
Optimal design (factorial and D-Optimal) (98). A common practice is to process the original 
data using principal component analysis (PCA) and subsequently to use the principal 
components (PCs) as design variables in a design selecting a small number of informative and 
representative training data. These principal components are suitable for experimental design 
purposes since they are orthogonal and limited in number, reducing the extent of collinearity 
in the training set. In fractional factorial design, all the principal components are explored at 
two, three or five levels. The training set includes one representative for each combination of 
components. The drawback of this approach is that it does not guarantee the closeness of the 
test set to the training set in the descriptor space. D-Optimal design is often performed 
whenever the classical symmetrical design cannot be applied, because the experimental region 
is not regular in shape or the number of compounds is selected by a classical design is too 
large. The basic principle of this method is to select compounds to maximize the determinant 
of the information (variance-covariance) matrix ¦ X’X¦  of independent variables. The 
determinant of this matrix is maximal when the selected compounds span the space of the 
whole data, i.e. when the most influential compounds (maximal spread) are selected. 
 
76. Sphere Exclusion is a dissimilarity-based compound selection method first described 
by Hudson et al. (104) and then later adapted by various groups (99, 105, 106). The algorithm 
consists in selecting molecules, whose similarities with each of the other selected molecules 
are not higher than the defined threshold (106). Therefore, each selected molecule creates a 
(hyper) sphere around itself, so that any candidate molecules inside the sphere are excluded 
from the selection. The radius of the sphere is an adjus table parameter, determining the 
number of compounds selected and the diversity between them. The original method starts 
with the “most descriptive compound” and in each cycle identifies the compound most similar 
to the centroid of the already selected compounds. This was considered to be very computer 
intensive, so variations from the original algorithm have been implemented to reduce the 
computer time required by selecting the next compound quicker. 
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Concluding remarks  
 
77. Ideally, QSAR modelling should lead to statistically robust models capable of making 
reliable predictions for new compounds. In this Guidance Document, reference is made to the 
reliability, rather than the correctness, of model predictions. This is because from a 
philosophical viewpoint, it is questionable whether a prediction can ever be correct, or 
whether a model can ever truly represent reality. As famously quoted by the chemist and 
statistician, George Box (91), “all models are wrong, but some are useful”.  
 
78. In order for a statistical model to be useful for predictive purposes, it should be built 
on a sufficiently large and representative amount of information regarding the modelled 
activity and should contain only relevant variables. As discussed in this chapter, a variety of 
statistical methods are available for assessing the goodness-of- fit, robustness and predictive 
ability of QSAR models, and a variety of statistics are routinely used to express these aspects 
of model performance. Modern statistical software packages provide convenient and 
automated means of applying these methods and generating a plethora of statistics. The users 
of (Q)SAR models, such as regulators, need a sufficient understanding of these statistics and 
the underlying methods in order to interpret the statistics according to their own purposes.  
 
79. The model user should be aware that the performance of a model, while being 
expressed in quantitative terms and on the basis of well-established techniques, is dependent 
on the choices by the (Q)SAR modeller. Different types of statistics are generated by different 
methods, and different values of the same statistics can be generated by altering the 
compositions of the training and test sets, or by altering the resampling routine in a cross-
validation procedure. This is why transparency in the statistical validation process is needed 
to form the basis of sound decision-making. 
 
80. Internal validation refers to the assessment of goodness-of- fit and robustness. The 
goodness-of- fit of a model to its training set can be regarded as the absolute minimum of 
information needed to assess model performance. It expresses the extent to which the model 
descriptors “account for” the variation in the training set, and most importantly whether the 
model is statistically significant. If the model is not statistically significant, or if it is 
significant but of poor fit, it cannot be expected to be useful for predictive purposes.  
 
81. The robustness of the model provides an indication of how sensitive the model 
parameters (and therefore predictions) are to changes in the training set. If the model is not 
robust to small perturbations in the training set, it is unlikely to be useful for predictive 
purposes. In practice, robustness can be a difficult concept to apply, because there are 
numerous ways of resampling the data, which affect the statistics generated. 
 
82. The distinction between internal and external validation has important practical 
implications. Models that are too complex (i.e overfitted) are unlikely to predict independent 
data as reliably as their internal validation statistics may imply. This problem is increasingly 
relevant as modern QSAR methods become more powerful and capable of handling large 
amounts of correlated information and a large number of noisy variables.  
 
83. Predictivity is perhaps the most difficult concept to apply. From a philosophical 
standpoint, it can be argued that it is impossible to determine an absolute measure of 
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predictivity, since it is highly dependent on the choice of statistical method and test set. 
Nevertheless, external validation, when performed judiciously, is generally regarded as the 
most rigorous assessment of predictivity, since predictions are made for chemicals not used in 
the model development. 
 
84. External validation should be seen as a useful supplement to internal validation, rather 
than as a substitute. External validation can be difficult to apply in a meaningful when data of 
sufficient quality are scarce. The model user should therefore be aware that the statistics 
derived by external validation could be less meaningful than those provided by internal 
validation, if the external test set is not carefully designed.  
 
85. It is not the aim of this document to define acceptability criteria for the regulatory use 
of QSAR models, since the use of data in decision-making is highly context-dependent. 
However, it is possible to identify features of models that are likely to contribute to a high or 
low performance. 
 
86. A model with high statistical performance is likely to have one or more of the 
following characteristics: 
a) the highest possible prediction power is achieved with the minimum number of 
variables; 
b) there is a low correlation between the predictor variables. 
 
87. A model with low statistical performance is likely to have one or more of the 
following characteristics: 
a) it is lacking one or more relevant variables, i.e. has insufficient fitting capability; 
b) there is a marked difference between goodness-of- fit and prediction power; 
c) one or more (noisy) variables are correlated with the response by chance; 
d) there is a high correlation between the predictor variables (multi-collinearity) 
resulting in redundancy in descriptor information. 
 
 
  48 
Table 4.1. Basic equations and parameters of goodness of fit in MLR 
N. Definition Equation and terms  
1 MLR equation 
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Table 4.2. Confusion or contingency matrix {cGG} for a general case with G classes 
 
  Assigned class 
  A1’ A2’ A3’ Ag’ Marginal totals 
A1 c11’ c12’ c13’ c1g’ n1 
A2 c21’ c22’ c23’ c2g’ n2 
A3 c31’ c32’ c33’ c3g’ n3 
True class 
Ag cG1’ cG2’ ck3’ Cgg’ ng 
 Marginal 
totals 
n1’ n2’ n3’ ng’  
 
 
Table 4.3. Example of loss matrix {lGG’} where the loss function has been arbitrarily defined 
in an integer scale 
 
  Assigned class 
  A1’ A2’ A3’ Ag’ 
A1 0 1 2 2 
A2 1 0 1 1  
A3 2 1 0 2 True class 
Ag 2 1 2 0 
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Table 4.4. Definitions of the goodness-of-fit parameters 
Statistic Formula Definition  
Concordance or  
Accuracy  
(Non-error Rate) 
100
'
´
å
n
c
g gg  
total fraction of objects correctly 
classified. 
 
cgg’ = number of objects correctly 
classified to each class 
n = total number of objects 
Error Rate n
cn
g ggå- '  
1-concordance 
total fraction of objects misclassified 
 
cgg’ = number of objects correctly 
classified to each class 
n = total number of objects 
NO-Model Error 
Rate, NOMER%) NOMER
n n
n
M% =
-
´ 100 
Error provided in absence of model 
 
nM  = number of objects of the most 
represented class 
n = total number of objects 
Prior probability of a 
class  G
Pg
1
=  
probability that an object belongs to a 
class supposing that every class has the 
same probability 
 
G = number of classes 
Prior proportional 
probability of a class  n
n
P gg =  
probability that an object belongs to a 
class taking into account the number of 
objects of the class  
 
ng = total number of objects belonging 
to class g 
n = total number of objects 
Sensitivity of a 
class 
100' ´
g
gg
n
c
 
percentage of objects correctly 
assigned to the class out of the total 
number of objects belonging to that 
class  
 
cgg’ = number of objects correctly 
classified to each class 
ng = total number of objects belonging 
to class g 
Specificity of a 
class 
100
'
' ´
g
gg
n
c
 
percentage of objects correctly 
assigned to the class out of the total 
number of objects assigned to that 
class  
 
cgg’ = number of objects correctly 
classified to each class 
ng’ = total number of objects assigned 
to class g 
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Misclassification 
risk 
( )
100' ´å
å ¢¢
g
g
gg gggg
n
Pcl
 
risk of incorrect classification (takes 
into account the number of 
missclassifications, and their 
importance) 
 
cgg’ = number of objects correctly 
classified to each class 
ng = total number of objects belonging 
to class g 
Pg = prior probability class 
 
Footnote: 
g=1,…, G (G = number of classes) 
 
 
Table 4.5. 22 ´ contingency table 
  Assigned class  
  Toxic Non-toxic Marginal totals 
Active a b a+b Observed (in vivo) class 
Non-active c d c+d 
 Marginal totals a+c b+d a+b+c+d 
 
 
Table 4.6. Definitions of the Cooper statistics 
 
Statistic Formula Definition  
Sensitivity  
(True Positive rate) a/(a+b) 
fraction of active chemicals correctly 
assigned 
Specificity 
(True Negative rate) d/(c+d) 
fraction of non-active chemicals correctly 
assigned 
Concordance or  
Accuracy 
( )
( )dcba
da
+++
+
 fraction of chemicals correctly assigned 
Positive Predictivity a/(a+c) fraction of chemicals correctly assigned as active out of the active assigned chemicals  
Negative Predictivty d/(b+d) 
fraction of chemicals correctly assigned as 
non-active out of the non-active assigned 
chemicals 
False Positive 
(over-classification) rate 
c/(c+d) 
1-specificity 
fraction of non-active chemicals that are 
falsely assigned to be active  
False Negative 
(under-classification) 
rate 
b/(a+b) 
1-sensitivity 
fraction of active chemicals that are falsely 
assigned to be non-active  
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Table 4.7. Definitions of the robustness and predictive parameters 
Statistic Definition Formula 
MSE 
Mean Squared 
Error 
 
( )[ ] ( ) ( )( )[ ] )()()()()( 222 bbbbbbb BVEEEEMSE +=---=-= bb  
b = estimator of the true value b   
b  = true value of a quantity 
E(b) =  expected value of b 
V(b) =  Variance of the estimator b 
B2(b) =  bias of the estimator b 
PRESS 
Predictive 
Residual Sum 
of Squares 
( )å -= i iii yyPRESS
2
/ˆ  
 
iy  = observed response for the i-th object 
iiy /ˆ  = response of the i-th object estimated by using a model 
obtained without using the i-th object 
Q2 
Explained 
variance in 
prediction 
( )
( )å
å
-
-
-=-=
i i
i iii
T yy
yy
SS
PRESS
Q
2
2
/2
ˆ
11  
 
TSS = total sum of squares 
iy  = observed response for the i-th object 
iiy /ˆ  = response of the i-th object estimated by using a model 
obtained without using the i-th object 
y  = average response value of the training set 
SDEP 
Standard 
Deviation 
Error of 
Prediction 
( )
n
yy
SDEP i iii
å -
=
2
/ˆ  
 
iy  = observed response for the i-th object 
iiy /ˆ  = response of the i-th object estimated by using a model 
obtained without using the i-th object 
n = the number of training objects 
K Multivariate 
correlation 
index 
( ) 10012
1
% ´
-
-
=
å å
p
p
p
K
m
m m
m
l
l
 
 
?m =  eigenvalues obtained from the correlation matrix of the data 
set X(n, p), 
n =  number of objects  
p = number of variables. 
2
extQ  
External 
explained 
variance  
( )
( )å
å
=
=
-
-
-=
ext
ext
n
i
i
n
i
ii
ext
yy
yy
Q
1
2
1
2
2
ˆ
1  
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iy  = observed response for the i-th object 
iyˆ  = predicted response for the i-th object 
y  = average response value of the training set  
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CHAPTER 5: MECHANISTIC RELEVANCE 
 
Summary of chapter 5 
 
This chapter provides guidance on the application of the principle, “a (Q)SAR should be 
associated with a mechanistic interpretation, if possible”. The chapter begins with a historical 
perspective citing several early examples of congeneric (Q)SAR models where the notion of 
mechanistic interpretation first began. It then goes on to describe examples of more recent 
(Q)SARs where mechanistic interpretations have been provided. The difference between what 
is meant by a mechanistic basis and a mechanistic interpretation is clarified through the use of 
these examples. The chapter also makes raises several discussion points and proposes 
potential areas for further research.  
 
Introduction 
 
1. A  mechanistic understanding of a (Q)SAR can add to the confidence in the model 
already established on the basis of its transparency and predictive ability. For this reason, a 
mechanistic understanding can contribute to the acceptance and use of a (Q)SAR. The intent 
of this principle is therefore to ensure that an assessment of the mechanistic association 
between the descriptors used in the model and the endpoint being predicted has at least been 
considered, and if there is a plausible mechanistic association, that this has been documented. 
However, depending on the intended application of the (Q)SAR, this kind of information 
could be regarding as unimportant, desirable or essential.  
 
2.  A molecular descriptor is a structural or physicochemical property of a molecule, or 
part of a molecule, which characterises a specific aspect of a molecule and is used as an 
independent variable in a QSAR. According to their physicochemical interpretation, 
descriptors are often classified into three general types (electronic, steric and hydrophobic).  
Table 5.1 provides a list of commonly used descriptors in (Q)SAR studies. 
 
3. It should be noted that a model based on transparent descriptors and on a transparent 
algorithm can always be given an interpretation, but the challenge is to assess the plausibility 
or likelihood of that interpretation. Such an assessment can only be made on a model-by-
model basis. Such an the assessment will depend partly on the state of knowledge in the field 
(i.e. knowledge of the features captured by the model descriptors and the (biological) 
relevance of the association between the descriptors and the endpoint. The assessment will 
also be partly subjective, depending on the training and experience of the individual. For this 
reason, the principle will be difficult to apply in a consistent way between different experts. 
 
4. From a philosophical standpoint, it is interesting to distinguish between the terms 
“mechanistic basis” and “mechanistic interpretation”. The term mechanistic basis refers to the 
development of a mechanistic hypothesis before modelling (a priori). The mechanistic 
hypothesis is proposed to determine which factors/properties are likely to be significant and 
thus which descriptors will be best to model that property. In such cases, it is important to use 
descriptors with a clear or widely accepted physicochemical interpretation. In contrast, 
mechanistic interpretation refers to the assignment of physical/chemical/biological meaning 
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to the descriptors after modelling (a posteriori). Thus, the descriptors used in the final model 
are interpreted as to their relevance to the toxicity under consideration.  
 
5. In practice, it can be difficult to distinguish between a priori and a posteriori 
interpretation of a model, because the modelling process often involves multiple iterations, 
starting from an exploratory data-mining step in which large numbers of descriptors are 
screened for predictive value, after which combinations of “promising” predictors are 
investigated, with the possible exclusion of descriptors that are considered to contain the same 
or similar information as other descriptors. 
 
Historical background 
 
6. The basic underlying principle of (Q)SARs is that the properties and biological 
interactions of a chemical with a defined system are inherent in its molecular structure. 
Attempts to develop (Q)SARs consist of looking for links between the structure and 
biological activity. These links may be mechanistically based or may be purely empirical. 
Ideally the activities and properties are connected by some known mathematical function, F:  
 
Biological activity = F (Physicochemical Properties)    (Eq 1) 
 
7. Around 1935, Hammett (108) made an enormous contribution to our ability to 
elucidate organic and eventually biochemical and biological reaction mechanisms. His 
reasoning was that similar changes in structure should produced similar changes in reactivity. 
Although original at the time, this reasoning is still used by organic chemists today. He 
postulated that the effect of substituents on the structure of benzoic acids could be used as a 
model system to estimate the electronic effects of substituents on similar reaction systems. 
The more electron attracting the substituent, the more rapid the reaction. Hammett defined a 
parameter, s. Positive values of s represented electron withdrawal by the substituent from the 
aromatic ring and negative values indicated electron release. 
 
8. Although the Hammett equation has been modified and extended, s constants still 
remain the most general means for estimating the electronic effects of substituents on reaction 
centres. The power of these simple s values is that they often take into account solution 
effects on substituents such as hydrogen bonding, dipole interactions and so on that are still 
difficult to calculate. 
 
9. Hammett’s reasoning was subsequeqntly extended to the development of steric and 
hydrophobic parameters. These extensions have enabled all kinds of structure-activity 
relationships of chemical reactions to be tackled.  
 
10. However the field of QSAR really started to flourish with the pioneering work of 
Corwin Hansch in the early 1960s. He proposed a mathematical model which correlated 
biological activity with chemical structure. He correlated the plant growth regulatory activity 
of phenoxyacetic acids to Hammett constants and partition coefficients (109). In 1964, 
Hansch et al. showed that the biological activity could be correlated linearly by free-energy 
related parameters (110). This approach became known as a Linear Free Energy Re lationship 
(LFER) and expressed in the following equation: 
 
log 1/C = ap+ bs + cES +..........+ constant       (Eq 2) 
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In Equation 2, C is the molar concentration of the compound to produce a defined biological 
response, p is the hydrophobic contribution of the substituent and represented by logPX/PH, s  
is the Hammett electronic descriptor of the substituents (111), represented by log KX/KH, ES is 
Taft’s steric parameter (112) and a, b and c are the appropriate coefficients. In these 
expressions PX and PH are the octanol/water partition coefficients of the substituted and 
unsubstituted compounds, respectively, and KX and KH are the ionization constants of the 
meta- or para-substituted and unsubstituted benzoic acids at 25 ºC, respectively. 
 
11. Hansch recognised the importance of partition effects on any attempt to describe the 
properties of a biological system. The reasoning behind this lay in the recognition that in 
order to exert an effect on a system the compound first had to reach that site of action. Since 
biological systems are composed of a variety of aqueous phases separated by membranes, 
measurement of partition coefficients in a suitable system of immiscible solvents was thought 
to provide a simple chemical model of these partition steps in the biological system. Hansch 
chose an octanol and water system. Octanol was chosen for a variety of reasons perhaps the 
most important of these that it consists of a long hydrocarbon chain with a relatively polar 
hydroxyl head group and therefore mimics some of the lipid constituents of biological 
membranes. The generalized form of what has now become known as the Hansch approach is 
shown as  
 
log 1/C = a p + bp2 + cs + dEs + constant       (Eq 3) 
 
 
In Equation 3, C is the dose required to produce a standard effect, pi, sigma and Es are 
hydrophobic, electronic and steric parameters and a,b,c,d are statistical parameters fitted by 
linear regression. Const is a constant. The squared term for pi is included in an attempt to 
account for non- linear relationships in hydrophobicity.   
 
12. The work of Hansch provided perhaps the first example of how a (Q)SAR could give 
information concerning mechanism. He and his workers (113) demonstrated the following 
relationship for a set of esters binding to the enzyme papain. 
 
Log 1/Km = 1.03p3’ + 0.57s + 0.61MR4 + 3.8      (Eq 4) 
N = 25, r = 0.907, s = 0.208 
 
In Equation 4, Km the Michaelis-Menten constant, is the substrate concentration at which the 
rate of the reaction is half maximal. The subscripts to the physicochemical parameters 
indicate substituent positions. The statistics quoted are the number of compounds in the 
dataset, the correlation coefficient, a measure of the goodness-of- fit and the standard error of 
the fit.  
 
13. Physicochemical meaning was assigned to the physicochemical parameters in 
Equation 4 as follows. The positive sigma term implied that electron withdrawing substituents 
favoured formation of the enzyme substrate complex. This made biological sense since the 
MOA of papain does involve the electron rich thiol group of a cysteine residue. The positive 
molar refractivity term suggested that bulkier substituents in the 4 position favoured binding. 
The two parameters p4 and MR4 are orthogonal to each other in the dataset implying that a 
bulk effect rather than a hydrophobic effect was important at position 4. The prime sign 
associated with the p parameter for position 3 indicated that in cases where there were two 
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meta substituents, the p value of more hydrophobic substituent was used, the other p 3 value 
being ignored. The rationale for this was that binding of one meta substituent to the enzyme 
placed the other into an aqueous region and therefore outside the enzyme binding site (114). 
 
14. Hansch’s early work clearly demonstrates the concept of mechanistic interpretation 
through the assignment of physicochemical meaning to the descriptors. This approach has 
been widely followed by other workers. Nowadays, Hansch analysis refers to the 
investigation of the quantitative relationship between the biological activity of a series of 
compounds and their physicochemical substituent or global parameters representing 
hydrophobic, electronic, steric and other effects using multiple regression techniques. 
 
15. Whilst the Hansch approach is mechanistically simple, it is somewhat limited in its 
breadth of application. Typically, Hansch-type QSARs are limited to congeneric series of 
chemicals i.e. groups of chemicals with a common parent structure (e.g. aliphatic alcohols). In 
practice,  it is desirable to develop a (Q)SAR that is applicable to a wider range of chemicals 
than a single series of chemicals with the same backbone. Thus, optimising maximum 
diversity in chemical structure with a sound mechanistic basis is an important challenge 
(Figure 5.1).  
 
16. The development of (Q)SARs has therefore evolved in an attempt to accommodate 
models which optimise the structural, data and mechanistic diversity. The two main 
approaches in the (Q)SAR development now are mechanistically based (Q)SARs and 
empirical (or correlative) (Q)SARs. These may be considered in the following way.  
 
17. Mechanism-based (Q)SARs are those (Q)SARs where a hypothesis is made as to the 
physicochemical properties or descriptors that are likely to be relevant. Statistical methods are 
then applied to seek out correlations existing between these descriptors and the endpoint of 
interest.  
 
18. In the case of purely empirical approaches, no assumptions are made as to the likely 
(biological) mechanism. A large number of physicochemical parameters or structural 
parameters are calculated and statistical approaches are applied to identify those features that 
correlate most closely with the biological activity.  
 
19. In both cases a physicochemical meaning can be assigned to interpret the descriptors 
after modelling, the only difference lies in whether descriptors are pre-determined with a 
mechanism in mind. In practice, (Q)SARs are often developed in an iterative manner, with 
some descriptors being included a priori on the basis of mechanistic “expectation”, and others 
being included a posteriori on the basis of mechanistic “discovery”. 
 
Recommendations for practitioners  
 
20. In this section, a few examples illustrate specific (Q)SARs where the concept of 
mechanistic interpretation or mechanistic basis has been applied. A range of (Q)SARs have 
been explored for both human health and environmental effects for endpoints, including 
mutagenicity, eye irritation, skin sensitisation, as well as aquatic toxicity. 
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Human Health Endpoints 
 
21. Benigni et al. (115) aimed to study some molecular determinants to discriminate 
between mutagenic and inactive compounds for aromatic and heteroaromatic amines and 
nitroarenes. Using a selection of data from the literature (both Ames and SOS repair), he 
investigated the feasibility of developing (Q)SARs. He found a dramatic difference between 
those (Q)SARs derived for estimating potency and those derived for predicting the absence or 
presence of activity. Hydrophobicity was found to play a major role in determining the 
potency of the active compounds whereas mainly electronic factors differentiated the actives 
from the inactives. The electronic factors were those expected on the basis of hypothesised 
metabolic pathways of the chemicals. Electronic factors together with size/shape appeared to 
determine the minimum requirement for the chemicals to be metabolised whereas 
hydrophobicity determined the extent of activity.  
 
22. Debnath et al. (116) modelled mutagenic potency in the TA98 strain of Salmonella 
typhimurium (+ S9 activation system) and derived the following equation for a set of 
aminoarenes: 
 
log TA98 = 1.08 log P + 1.28 HOMO – 0.73 LUMO + 1.46 IL + 7.20  (Eq 5) 
n = 88, r = 0.898 (r2 = 0.806), s = 0.860, F 1,83 = 12.6 
 
The mutagenic potency (log TA98) was expressed as log (revertants/nmol). IL in the equation 
was an indicator variable that assumed a value of 1 for compounds with three or more fused 
rings. Overall, the principal factor affecting the relative mutagenicity of the aminoarenes was 
their hydrophobicity (logP). Mutagenicity increased with increasing HOMO values; this 
positive correlation seemed reasonable since compounds with higher HOMO values are easier 
to oxidize and should be readily bioactivated. For the negative correlation with LUMO, no 
simple explanation could be offered. 
 
23. Barratt (117) proposed a mechanism-based model for predicting the eye irritation 
potential of neural organic chemicals,  as measured in the rabbit draize eye test. A substance 
which is classified as irritating to eyes according to EC criteria is one which causes a defined 
degree of trauma in the Draize rabbit eye test following the instillation of 0.1ml (or equivalent 
weight) as defined in the EC Annex V method (118) and the OECD Test Guideline 405 (119). 
Neutral organics were described as uncharged, carbon-based chemicals which did not possess 
the potential to react covalently with or to ionize under the conditions prevalent in biological 
systems. Common chemical classes covered by this definition were hydrocarbons, alcohols, 
ethers, esters, ketones, amides, unreactive halogenated compounds, unreactive aromatic 
compounds and aprotic polar chemicals. Data on 38 neutral organics taken from the reference 
databank of eye irritation data published by ECETOC (European Centre for Ecotoxicology 
and Toxicology) (120) together with 8 chemicals drawn from work by Jacob & Martens (121) 
was analysed using principal components analysis (PCA). The mechanistic hypothesis 
underlying this (Q)SAR was summarized as follows. Neutral organic chemicals were irritant 
as a result of the perturbation of ion transport across cell membranes. These perturbations 
arise from changes in the electrical properties of the membrane and are related to dipole 
moments of the perturbing chemicals. In order to affect these electrical properties, a chemical 
must be able to partition into the membrane and hence possess the appropriate 
hydrophobic/hydrophilic properties. An appropriately small cross sectional area allowing it to 
fit easily between lipid components of the membrane was also a requirement. Log P was used 
as a measure of hydrophobicity. The minor principal inertial axes Ry and Rz were used to 
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represent the cross-sectional area and the dipole moment was used to model the reactivity. 
Plots of the first two principal components of these parameters showed that PCA was able to 
discriminate well between the irritant and non- irritant chemicals in the dataset. 
 
24. Abraham and his workers followed a similar mechanistic based approach. In this 
example a collection of data on the Draize rabbit eye test was analysed (122) using the set of 
Abraham (123) descriptors. These descriptors included R2, excess molar refraction, p2H 
polarisability/dipolarity, åa2H and åb2H effective hydrogen bond acidity and basicity and Log 
L16 a descriptor where L16 is the vapour-hexadecane solubility at 25°C. A possib le model 
process would be that of transfer of a pure organic liquid to a dilute solution in an organic 
solvent phase. The equilibrium constant governing such a model process is known as the 
activity coefficient, g°, which may be defined for a sparingly soluble liquid as the reciprocal 
of the solubility of the liquid in the organic solvent phase. Abraham defined the solubility of a 
vapour into a solvent phase as L, where L = (1/g°)/P°. If the Draize eye score (DES) were 
related to a transport driven mechanism, the transfer process would be from the pure organic 
liquid into an initial biophase that will be the tear film and cell membranes on the surface of 
the eye. The more soluble the organic liquid in the initial phase, the larger the DES and hence 
greater irritation. Thus DES values would be proportional to 1/g°°, the physicochemical 
solubility and hence Log(DES/P°) = Log L where P° is the saturated vapour pressure in ppm 
at 25°C. A general equation for the correlation and prediction of a series of Log L values for 
solutes into a given condensed phases had already been established.  
 
Log SP = c + r R2, + sp2H +a åa2H +b åb2H + 1. Log L16    (Eq 6) 
 
Application of Eq 6 to Log(DES) values yielded an extremely poor correlation but when 
Log(DES/P°) was used as the dependent variable, a strong relationship (Eq 7) was found. 
 
Log(DES/P°) = - 6.955 + 0.1046p2H + 4.437 åa2H + 1.350 åb2H + 0.754 Log L16   (Eq 7) 
n = 37, r2 = 0.951, SD = 0.32, F = 155.9  
 
On transforming the calculated Log(DES/P°) values back to calcula ted DES values, there was 
good agreement with the original DES values (Eq 8).  
 
Log(DES)obs = 0.022 + 0.979 Log(DES)calc      (Eq 8) 
n = 37, r2 = 0.771, SD = 0.3, F = 117.6 
 
It was suggested that the DES/ P° values referred to the transfer of the irritants from the 
vapour phase to the biophase and hence that a major factor in the Draize eye test was simply 
the transfer of the liquid (or the vapour) to the biological system.  
 
25. Models for skin sensitisation have varied from those based on an a priori approach to 
those interpreted a posteriori. An example of both is described here. The first 
physicochemical mathematical model for skin sensitisation was the RAI (Relative Alkylation 
Index) model (124). This index quantifies the relative extent of sensitiser binding to the skin 
protein as a function of the dose given, the chemical reactivity (which could be expressed in 
the terms of the measured rate constants for reaction with a model nucleophile, in terms of 
Taft or Hammett substituent constants or in terms of computed molecular orbital indices) and 
hydrophobicity expressed as the octanol/water partition coefficient. The general form of the 
RAI expression is: 
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RAI = Log D + a Log k + b Log P        (Eq 9) 
 
where D is dose, k is the relative rate constant and P is the octanol/water partition coefficient. 
Log P here models both penetration and lipid/polar fluid partitioning. 
 
26. Topological indices are often thought of as being different to interpret. In this example 
a model for skin sensitisation was developed relating the potency of a set of 93 diverse 
chemicals to a range of topological indices (125). The indices used in the final model 
accounted for hydrophobicity (H), polar surface area (PS), molar refractivity (MR), 
polarisability (PSR), charges (GM), van der Waals radii (VDW). Such parameters can be 
assigned as relevant in the context of skin sensitisation in that partition could be modelled by 
hydrophobicity, polar surface area, molar refractivity, van derWaals radii as bulk parameters 
and the reactivity accounted for by polarisability and charges. The Topological Sub-Structural 
Molecular Design (TOPS-MODE) approach used in this example is based on the method of 
moments (126, 127, 128). The approach consists of using the topological bond matrix (edge 
adjacency matrix) of the molecular graph. Bond weights in the main diagonal entries of the 
bond matrix are used to account for effects that could be involved in biological processes. An 
advantage with this approach is that a structural interpretation of TOPS-MODE results can be 
carried out by using the bond contributions to skin sensitization. These are calculated on the 
basis of the local moments which are defined as the diagonal entries of the different powers of 
the weighted bond matrix. This provides a mechanistic interpretation at a bond level and 
enables the generation of new hypotheses such as structural alerts. 
 
Environmental Endpoints 
 
27. The following (Q)SAR, taken from the European Technical Guidance Document for 
chemical risk assessment (129), predicts the acute toxicity of organic chemicals to the fathead 
minnow (Pimephales promelas). The equation developed was: 
 
Log (LC50) = -0.846 log Kow - 1.39        (Eq 10) 
 
where LC50 is the concentration (in moles per litre) causing 50% lethality in Pimephales 
promelas, after an exposure of 96 hours; and Kow is the octanol-water partition coefficient.  
 
28. The (Q)SAR was developed for chemicals considered to act by a single mechanism of 
toxic action, non-polar narcosis, as defined by Verhaar et al.. (130), and therefore has a clear 
mechanistic basis. In fact, non-polar narcosis is one of the most established mechanisms of 
toxic action. Non-polar narcosis has been established experimentally by using the Fish Acute 
Toxicity Syndrome methodology (131). The (Q)SAR is based on a descriptor for 
hydrophobicity (log Kow), which is relevant to the mechanism of action, i.e. toxicity results 
from the accumulation of molecules in biological membranes.  
 
Expert Systems 
 
29. An expert system for predicting toxicity is considered to be any formalised system not 
necessarily computer based, which enables a user to obtain rational predictions about the 
toxicity of chemicals. All expert systems for the prediction of chemical toxicity are built upon 
experimental data representing one or more manifestations of chemicals in biological systems 
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(the database) and/or rules derived from such data (the rulebase). Individual rules within the 
rulebase are generally of two main types. Some rules are based on mathematical induction 
whereas other rules are based on existing knowledge and expert judgement. Typically induced 
rules are QSARs whereas expert rules are often based on knowledge about reactive chemistry. 
Expert systems are sometimes characterized according to the nature of the rules in their 
rulebase. An expert system based primarily on statistically induced rules is sometimes called 
an “automated rule- induction system”, whereas a system based primarily on expert rules is 
referred to as a “knowledge based system” (132). The following two examples, referring to 
ECOSAR and DEREKfW, outline the mechanistic interpretation for these two types of expert 
system. 
 
30. As part of the work by the OECD (Q)SAR Group, the ECOSAR tool was evaluated 
with respect to the OECD principles (5). ECOSAR (133, 134) predicts defined endpoints as 
required by the US EPA regulatory framework, such as acute L(E)C50 and long-term NOECs 
for fish, daphnids and algae. The (Q)SAR equations are based on linear regression analysis, 
using log Kow as the sole descriptor for predicting the L(E)C50 values (except for the class of 
surfactants). There is no explicit description of the chemical classes or the exclusion rules. 
The (Q)SAR for neutral organics is based on the assumption that all chemicals have a 
minimal toxicity based on the interference of the chemical with biological membranes, which 
can be modelled by the octanol-water partition coefficient (Kow). All other chemical classes 
show excess toxicity compared to the neutral organics.  
 
31. DEREKfW is a knowledge-based expert system created with knowledge of structure-
toxicity relationships and an emphasis on the need to understand mechanisms of action and 
metabolism. The DEREK knowledge base covers a broad range of toxicological endpoints, 
including mutagenicity, carcinogenicity and skin sensitisation. 
 
32. The expert knowledge incorporated into the DEREKfW system originated from 
Sanderson & Earnshaw (135). These workers identified a series of ‘structural alerts’ 
associated with certain types of toxic activity. The DEREK knowledge base was written, 
developed and continues to be enhanced by LHASA (Logic and Heuristics Applied to 
Synthetic Analysis) Ltd and its members at the School of Chemistry, University of Leeds, 
UK. LHASA Ltd is a non-profit making collaboration consisting of the University of Leeds 
and various other educational and commercial institutions (including agrochemical, 
pharmaceutical and regulatory organizations) created to oversee the development of the 
DEREKfW system and the evolution of its toxicity knowledge base. 
 
33. DEREKfW provides an explicit description of the substructure and substituents. When 
a query structure is processed, the alerts that match are displayed in a hierarchy called the 
prediction tree and are highlighted in bold in the query structure. The prediction tree includes 
the endpoint, the species and reasoning outcome, the number and name of the alert, and the 
example from the knowledge base if it exactly matches the query structure. The alert 
description provides a description depicting the structural requirement for the toxicophore 
detected and a reference to show the bibliographic references used. Some rules are extremely 
general with substructures only taking into account the immediate environment of a functional 
group. This means that remote fragments that may modulate a toxicity are not always taken 
into consideration. In other cases, the descriptions are much more specific.  
 
34. All the rules in DEREK are based on either hypotheses relating to mechanisms of 
action of a chemical class or observed empirical relationships, the ideas for which come from 
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a variety of sources, including published data or suggestions from the DEREK collaborative 
group. This group consists of toxicologists who represent LHASA Ltd and customers who 
meet at regular intervals to give advice and guidance on the development of the databases and 
rulebases. The hypotheses underpinning each alert are documented in the alert descriptions as 
comments. These comments often include descriptions of features acting as electrophiles or 
nucleophiles. However, the detail depends on the specific alert. Some alerts contain no 
comments, apart from the modulating factors of skin penetration. 
 
Artificial Intelligence systems 
 
35. Many of the models so far discussed involve the use of transparent algorithms, 
typically regression equations where the mechanistic interpretation is achieved by interpreting 
the descriptors, the size of their coefficients, and perhaps the mathematical form of the 
equation. In contrast, AI-based models are sometimes considered to be non-transparent, since 
the algorithms are deeply embedded.  
 
36. For example, Kohonen networks are specific types of networks that can provide 
mechanistic insights. Graphical representations of individual layers may indicate the roles of 
individual descriptors in the model. When a new compound is presented to the model it will 
be located on a defined position in the Kohonen network.. Its mechanism of activity may be 
deduced from the mechanisms of neighbouring compounds. 
 
Concluding remarks 
 
37. There are many types of different types of modelling approaches. In this chapter, 
guidance is presented through the use of examples, to illustrate how to consider mechanism in 
the context of different types of model. 
 
38. The mechanistic rationale of a (Q)SAR can be established a priori, in which case the 
descriptors are selected before modelling on the basis of their known or anticipated role in 
driving the response, or a posteriori, in which case the descriptors are selected on the basis of 
statistical fit alone, with their mechanistic rationale being rationalised after modelling. Models 
can also be developed by a combination of these two approaches. 
 
39. In the case of a QSAR with continuous descriptors, a mechanistic interpretation can be 
based on the physicochemical interpretation of each descriptor and its association with a mode 
or mechanism of action. The magnitudes of the model coefficients and model structure might 
also be taken into consideration. 
 
40.  In the case of a SAR, a mechanistic interpretation can be based on the chemical 
reactivity or molecular interaction of the substructure.  
 
41. In the case of expert systems, it is not possible to generalise how a mechanistic 
interpretation could be assigned, due to the variety of such systems. Some systems are based 
primarily on expert knowledge, whereas others are based primarily on learned rules. For 
example, DEREK for Windows is based on the use of multiple structural alerts, each of which 
has its own scientific supporting evidence; whereas METEOR and CATABOL incorporate a 
significant amount of information on known metabolic pathways.  
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The architecture of neural network models does not generally correspond in any obvious way 
with underlying mechanisms of action. 
 
 
 
Figure 5.1.  The Balance between Structural, Data and Mechanistic diversity 
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Table 5.1. Commonly used molecular descriptors in QSAR studies 
  
Molecular descriptor Physicochemical interpretation Examples of QSAR 
applications  
Logarithm of the Partition 
coefficient: 
log P = log (Corg /Cwater) 
Corg = concentration of the 
non-ionised solute in the 
organic phase 
Cwater = concentration of the 
non-ionised solute in the water 
phase 
Describes the distribution of a 
compound between organic (usually 
octanol) and water phase 
logP>0 – greater solubility in the 
organic phase; 
logP<0 – greater solubility in the 
aqueous phase. 
Measure of hydrophobicity / 
lipophilicity 
Many applications in QSAR 
analysis of toxicological data 
sets (136) 
Hydrophobic substituent   
constant (p) : 
pX = logPR-X – logPR-H 
logPR-H = logP of the parent 
compound 
logPR-X = logP of X substituted 
derivative  
Describes the contribution of a 
substituent to the lipophilicity of a 
compound. 
QSAR for mutagenicitiy of 
substituted N-nitroso-N-
benzylmethylamines (137, 
138) 
Hammett electronic 
substituent constant (s ): 
log(Kax/KaH) = rs 
KaH = acid dissociation 
constant of benzoic acid 
Kax = acid dissociation 
constant of X substituted 
derivative of benzoic acid 
r = a series constant 
Describes the electron-donating or -
accepting properties of an aromatic 
substituent, in the ortho, meta and 
para positions. 
QSARs of the relative 
toxicities of monoalkylated or 
monohalogenated benzyl 
alcohols (139) 
Taft steric parameter (ES) : 
SEkk dsr ++=
**
0loglog  
s * = polar substituent constant 
? = constant 
Steric substituent constant. 
Describes the intramolecular steric 
effects on the rate of a reaction. 
Original reference of the 
formulation of Taft steric 
parameter (140) 
Aqueous solubility (Saq) : 
The maximum concentration 
of the compound that will 
dissolve in pure water at a 
certain temperature, at 
equilibrium 
Measures the hydrophilicity of a 
compound  
QSARs for fish 
bioconcentration factor (141) 
Molecular refractivity (MR): 
MR = [(n2–1)/(n2+ 2)]*M/r 
n = refractive index 
M = relative molecular mass 
r = density 
Describes the size and polarizability 
of a fragment or molecule. It could 
be considered as both an electronic 
and a steric parameter. 
QSARs for binding of 
tetrahydroisoquinoline 
derivatives with dstrogen 
receptors (142) 
Dissociation Constant (pKa) Describes extent of ionization of a 
compound. 
Reflects electron-directing effects of 
substitutents. 
QSARs for relative toxicity of 
monosubstituted phenols 
(143) 
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Dipole moment 
Determined via experimental 
measurement of dielectric 
constant, refractive index and 
density, or calculated using 
molecular orbital theory 
Describes separation of charge 
(polarity) in a molecule, and also 
considered as measure of 
hydrophilicity. Hypothesised to 
reflect the influence of electrostatic 
interactions with biological 
macromolecules (144) 
QSARs for eye irritation of 
neutral organic chemicals 
(145) 
Atomic charge  
Calculated by different 
molecular orbital methods 
Descriptor that determines the 
electrostatic potential around a 
molecule, thus influencing 
intermolecular interactions with 
electrostatic nature. 
QSARs for mutagenicity of 
quinolines (146) 
HOMO (Highest Occupied 
Molecular Orbital) and 
LUMO (Lowest Unoccupied 
Molecular Orbital) reactivity 
indices. 
Calculated using molecular 
orbital theory. 
Descriptors of molecular orbital 
energies. The HOMO energy 
describes the nucleophilicity of a 
molecule, whereas the LUMO 
energy describes electrophilicity. 
 
 
Mutagenicity of aromatic and 
heteroaromatic amines (146, 
147) 
 
Hydrogen bonding 
Various measures have been 
proposed. 
Descriptors of chemical reactivity 
(electrostatic interactions between 
molecules). Hydrogen-bond donors 
are proton donors (electronegative 
atoms or groups) and hydrogen-
bond acceptors are groups with the 
capacity to donate a lone electron 
pair. 
Modelling of aquatic toxicity 
of environmental pollutants 
(148) 
Molecular weight (MW) and 
Molecular volume (MV): 
MV = MW/r 
r - density 
 
Simple molecular size descriptors. QSPR models for in vivo 
blood-brain partitioning of 
diverse organic compounds 
(149) 
QSARs of a series of 
xanthates as inhibitors and 
inactivators of cytochrome 
P450 2B1 (150) 
Molecular surface area 
(MSA) 
 
Size descriptor defined on the basis 
of the van der Waals surface of an 
energy minimised molecule by 
excluding gaps and crevices 
Prediction of blood-brain 
partitioning  for structurally 
diverse molecules (151) 
 
Topological Descriptors  
Numerous types have been 
proposed, e.g. Wiener, Randic, 
Zagreb, Hosoya, Balaban, 
Kier and Hall molecular 
connectivity indices, kappa 
indices 
 
Descriptors based on chemical 
graph theory, calculated from the 
connectivity tables of molecules. 
 
Used to express different aspects of 
the shape and size of molecules, 
including degree of branching, and 
flexibility. 
 
Modelling structural 
determinants of skin 
sensitisation (125, 152) 
QSAR of Phenol Toxicity 
(153) 
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Electrotopological 
descriptors  
Atom-based topological descriptors 
that encode information about the 
topological environment and 
electronic interactions of the atom. 
QSAR Models for 
Antileukemic Potency of 
Carboquinones (154) 
Electronic Density Function 
(?)  
 
Obtained from Quantum 
Chemical Calculations. 
Descriptors of molecular similarity, 
based on electrostatic and steric 
interactions of the molecule  
QSAR of antimycobacterial 
benzoxazines (155) 
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Introduction 
According to the OECD principles for (Q)SAR validation, a (Q)SAR should be associated 
with the following information: 
 
1) a defined endpoint 
2) an unambiguous algorithm 
3) a defined domain applicability 
4) appropriate measures of goodness-of- fit, robustness and predictivity 
5) a mechanistic interpretation, if possible 
 
 
This Appendix provides a series of questions associated with each princip le, intended to 
provide an overview of the main considerations associated with the application of each 
principle. The questions are neither intended to be definitive, nor equally relevant for a given 
type of model. 
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CHECK LIST FOR PROVIDING GUIDANCE ON THE INTERPRETATION OF 
THE OECD PRINCIPLES FOR (Q)SAR VALIDATION 
 
 
 
PRINCIPLE  CONSIDERATIONS 
 Is the following information available for the model ? Yes/No/NA 
   
1) Defined endpoint 
1.1 A clear definition of the scientific purpose of the model (i.e. does it make 
predictions of a clearly defined physicochemical, biological or environmental 
endpoint) ? 
 
1.2 The potential of the model to address (or partially address) a clearly defined 
regulatory need (i.e. does it make predictions of a specific endpoint associated 
with a specific test method or test guideline) ? 
 
1.3 Important experimental conditions that affect the measurement and therefore 
the prediction (e.g. sex, species, temperature, exposure period, protocol) ? 
 
1.4 The units of measurement of the endpoint ?  
   
 
2) Defined algorithm 
2.1 In the case of a SAR, an explicit description of the substructure, including an 
explicit identification of its substituents ? 
 
2.2 In the case of a QSAR, an explicit definition of the equation, including 
definitions of all descriptors ? 
 
   
 
3) Defined domain of applicability 
3.1 In the case of a SAR, a description of any limits on its applicability (e.g. 
inclusion and/or exclusion rules regarding the chemical classes to which the 
substructure is applicable) ?  
 
3.2 In the case of a SAR, rules describing the modulatory effects of the 
substructure’s molecular environment ? 
 
3.3 In the case of a QSAR, inclusion and/or exclusion rules that define the 
following variable ranges for which the QSAR is applicable (i.e. makes reliable 
estimates): 
a) descriptor variables ? 
b) response variables ? 
 
3.4 A (graphical) expression of how the descriptor values of the chemicals in the 
training set are distributed in relation to the endpoint values predicted by the 
model ? 
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4A) Internal performance  
4.1 Full details of the training set given, including details of: 
a) number of training structures 
b) chemical names 
c) structural formulae 
d) CAS numbers  
e) data for all descriptor variables 
f) data for all response variables  
g) an indication of the quality of the training data ? 
 
4.2 a) An indication whether the data used to the develop the model were 
based upon the processing of raw data (e.g. the averaging of replicate 
values) 
b) If yes to a), are the raw data provided ? 
c) If yes to a), is the data processing method described ? 
 
4.3 An explanation of the approach used to select the descriptors, including: 
a) the approach used to select the initial set of descriptors 
b) the initial number of descriptors considered  
c) the approach used to select a smaller, final set of descriptors from a 
larger, initial set  
d) the final number of descriptors included in the model ? 
 
4.4 a) A specification of the statistical method(s) used to develop the model 
(including details of any software packages used)  
b) If yes to a), an indication whether the model has been independently 
confirmed (i.e. that the independent application of the described statistical 
method to the training set results in the same model) ? 
 
4.5 Basic statistics for the goodness-of- fit of the model to its training set (e.g. r2 
values and standard error of the estimate in the case of regression models) ? 
 
4.6 a) An indication whether cross-validation or resampling was performed  
b) If yes to a), are cross-validated statistics provided, and by which method  
? 
c) If yes to a), is the resampling method described ? 
 
4.7 An assessment of the internal performance of the model in relation to the 
quality of the training set, and/or the known variability in the response ? 
 
   
4B) Predictivity 
   
4.8 An indication whether the model has been validated by using a test set that is 
independent of the training set ? 
 
 
4.9 If an external validation has been performed (yes to 4.8), full details of the test 
set, including details of: 
 
a) number of test structures 
b) chemical names 
c) structural formulae 
d) CAS numbers  
e) data for all descriptor variables 
f) data for all response variables 
g) an indication of the quality of the test data ? 
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4.10 If an external validation has been performed (yes to 4.8): 
a) an explanation of the approach used to select the test structures, 
including a specification of how the applicability domain of the model is 
represented by the test set ? 
b) a specification of the statistical method(s) used to assess the predictive 
performance of the model (including details of any software packages 
used) 
c) a statistical analysis of the predictive performance of the model (e.g. 
including sensitivity, specificity, and positive and negative predictivities 
for classification models)  
d) an evaluation of the predictive performance of the model that takes into 
account the quality of the training and test sets, and/or the known 
variability in the response 
e) a comparison of the predictive performance of the model against 
previously-defined quantitative performance criteria ? 
 
 
   
 
 
5) Mechanistic interpretation 
5.1 In the case of a SAR, a description of the molecular events that underlie the 
properties of molecules containing the substructure (e.g. a description of how 
substructural features could act as nucleophiles or electrophiles, or form part or 
all of a receptor-binding region ) ? 
 
5.2 In the case of a QSAR, a physicochemical interpretation of the descriptors that 
is consistent with a known mechanism of (biological) action ? 
 
5.3 Literature references that support the (purported) mechanistic basis ?  
5.4 An indication whether the mechanistic basis of the model was determined a 
priori (i.e. before modelling, by ensuring that the initial set of training 
structures and/or descriptors were selected to fit a pre-defined mechanism of 
action) or a posteriori (i.e. after the modelling, by interpretation of the final set 
of training structures and/or descriptors) ? 
 
   
 
